Complications During Anaesthesia

Published on 27/02/2015 by admin

Filed under Anesthesiology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 5 (1 votes)

This article have been viewed 2373 times

Complications During Anaesthesia

Complications are unexpected and unwanted events. They occur in approximately 10% of anaesthetics. Only the minority of these complications cause lasting harm to the patient. Death complicates five anaesthetics per million given in the UK (0.0005%). Every complication has the potential to cause lasting harm to the patient. Therefore, deviations from the norm must be recognized and managed promptly and appropriately.

The most frequent complications during anaesthesia are arrhythmia, hypotension, adverse drug effects and inadequate ventilation of the lungs. Inadequate ventilation may be caused by poorly managed or difficult tracheal intubation, pulmonary aspiration of gastric contents, breathing system disconnections or gas supply failure. These complications are also the major causes of anaesthetic mortality, preventable intraoperative cardiac arrest and permanent neurological damage. In particular, hypotension and hypoxaemia are implicated consistently in studies of adverse outcome from anaesthesia.

CAUSES OF COMPLICATIONS

Human Error

Human error is a common contributor to anaesthetic complications, often in association with poor monitoring, equipment malfunction and organizational failure. Human error is commonly associated with poor training, fatigue, inadequate experience and poor preparation of the patient, the environment and the equipment. These conditions are, generally, avoidable, and good organization should usually prevent such circumstances. When complications do occur, effective monitoring and vigilance allow a greater period for action before the complication grows in severity. During this ‘window’, when the complication is apparent but has not yet damaged the patient, the anaesthetist must act with precision. Such precision of action may be obtained through the use of ‘action plans’ or ‘drills’ that have been rehearsed previously.

AVOIDANCE OF COMPLICATIONS

The most effective steps in preventing harm from complications are implemented before the complication occurs. Thorough preparation should prevent the majority of complications. This preparation includes:

Monitoring

Monitoring systems have been designed to detect and prevent complications during anaesthesia. Aspects of the patient should be monitored that are likely to deviate from the norm, or that are dangerous if they deviate from the norm. The Association of Anaesthetists of Great Britain and Ireland (AAGBI) has produced guidelines stipulating the acceptable minimum level of intraoperative monitoring (see Ch 16).

Modern monitoring systems have automatically activated alarms, and the anaesthetist chooses the values at which these alarms sound. The default values are not always the optimal choices. Thought should be applied to the values at which the anaesthetist gains useful insight into the patient’s deviation from the healthy status quo, without generating unnecessary visual and auditory pollution which may detract from the anaesthetist’s concentration and reduce the effectiveness of the monitor. In general, alarms should sound before the value in question reaches a potentially damaging level, but should not sound at values that would be considered within the patient’s expected range. Clearly, this is different for each patient, whose coexisting disease, age, anaesthesia and surgical procedure vary greatly. The repeated sounding of an alarm should not trigger reflex silencing of the alarm but should cause the anaesthetist to consider if treatment of the patient is required or if the alarm limit should be altered.

MANAGEMENT OF COMPLICATIONS

Generic Management of Complications

The majority of complications that result in serious harm to the patient compromise the delivery of oxygen to tissues. Organs which are damaged most rapidly by a deficiency in oxygen supply include the brain and heart. The liver and the kidneys are less fragile, but potentially at risk from even short interruptions of oxygen supply. Cessation of perfusion results in more rapid damage to organs than low levels of oxygenation while perfusion is maintained. Treatment must be provided rapidly when organ perfusion is threatened or when arterial oxygenation is impaired. The management of virtually any significant complication should include the provision of a high inspired oxygen fraction and the assurance of an adequate cardiac output.

In general, complications should be dealt with through a sequence of:

The Evolving Problem

The early recognition of an evolving problem allows the anaesthetist time to manage a complication before it damages the patient. Appropriate selection of monitoring alarm limits and the anaesthetist’s vigilance should allow more time for pre-emptive treatment can be provided to reduce the impact of the complication.

The first response to an emerging complication should be to minimize the potential harm to the patient. Such harm may be produced by the anaesthetist’s treatment or by a pathological source. It is important to ensure that an abnormal reading from a monitor is not an artefact; inaccurate information may be displayed if, for example, a pulse oximeter probe is poorly positioned or if an ECG electrode becomes displaced and the anaesthetist should ensure, through rapid clinical assessment of the patient, that the values shown on the monitor screen are consistent with the patient’s clinical appearance and the context. For example, a sudden reading of arterial oxygen saturation of 70% when the values have been greater than 96% throughout the procedure should prompt a rapid examination of the patient; if the patient is not cyanosed and ventilation appears to continue uninterrupted, then the position of the pulse oximeter probe should be checked, particularly if the plethysmograph trace is poor.

In most situations in which complications become apparent, the diagnosis is simple and treatment may progress in a linear fashion. Such linear treatment of complications is detailed later in this chapter. However, the causes of some complications, such as hypoxaemia, are not always immediately clear, and several potential aetiologies may exist. Where the differential diagnoses relating to a problem appear equally likely, the anaesthetist should treat the problem that threatens the most harm to the patient. During the management of problems during anaesthesia, the anaesthetist must constantly be reconsidering the list of differential diagnoses, re-arranging them mentally in order of likelihood and treating the most likely and most dangerous possibilities first.

Record-Keeping

Record-keeping, while useful in preventing complications, is also important during complications. Trends in a patient’s physiological data may become apparent only when charted, and new differential diagnoses may be generated through examination of the recorded data. Review of critical incidents and complications is vitally important in preventing future repetitions of the incident and in providing continuing education to individual practitioners and to Departments of Anaesthesia. Thorough record-keeping is vital in allowing informed review of these cases. Finally, some complications result in harm to the patient and it is very important for the practitioner and the patient that detailed records are available for later review. In a minority of such cases, legal action may result and detailed, legible records are vital in defending the actions of the staff and in providing an adequate explanation to the patient (and possibly to the court) of what happened in the operating theatre.

MEDICOLEGAL ASPECTS OF COMPLICATIONS

A minority of complications result in a formal complaint, but litigation by patients who feel that they have been wronged by the healthcare system is becoming increasingly common. Defensive practice is consequently becoming widespread. Such practice aims to reduce the potential culpability of the anaesthetist should complications arise. In some situations, this may lead to overinvestigation of patients and even to the provision of care which is not necessarily optimal for the patient. The ‘culture of blame’ in which we now practise dictates that anaesthetists must protect themselves as well as their patients. Meticulous record-keeping, preoperative information and consent, and frank discussion of risks with the patient are vital.

Management of the Medicolegal Aspects of Complications

Complications must be recognized promptly and treated efficiently, with the patient’s best outcome the aim of treatment. Record-keeping must continue to be meticulous, even during the occurrence of problems during an anaesthetic. Help should be sought early if there is any doubt about the anaesthetist’s ability or experience.

Complaints by patients should be dealt with promptly and professionally. The complaint and the anaesthetist’s response must be recorded clearly in the patient’s records. The anaesthetist should express regret and sympathy that the complication has occurred, and explain why. A frank discussion of the difficulties that occurred during an anaesthetic may provide the patient with sufficient information. If human error has occurred, then the anaesthetist should apologize, and assure the patient that further information will be provided when it becomes available. If the anaesthetist is a trainee, then it is prudent to enlist the assistance of a consultant to attend discussions with the patient. The clinical director should be informed of all discussions with the patient. It may be prudent that the clinical director accompanies the anaesthetist during their dealings with the patient. The results and content of all such discussions must be recorded in the patient’s medical records.

Any complaint that goes further than an informal conversation should be referred to the hospital’s complaints department and the anaesthetist’s defence organization should be informed. The defence organization will provide advice on subsequent action. It must be emphasized that throughout this often distressing process, meticulous and professional record-keeping may make the difference between exoneration and condemnation, irrespective of the true source of fault.

Respiratory System

Respiratory Obstruction

Table 43.1 details the common causes of respiratory obstruction during anaesthesia. Obstruction may occur at any point from the gas delivery system through the patient’s airway and bronchi to the expiratory parts of the breathing system and the scavenging tubing. It is common and potentially very dangerous. The commonest sites for obstruction are the larynx (e.g. laryngospasm), the tracheal tube (e.g. biting or secretions) and the bronchi (e.g. bronchospasm). Respiratory obstruction causes inadequate ventilation and impaired gas exchange. This causes hypercapnia, hypoxaemia and reduced uptake of volatile anaesthetic agent. Respiratory obstruction prevents the mass inflow of ambient gas which occurs during apnoea and thus produces hypoxaemia more rapidly than does apnoea with an open airway.

Partial obstruction is indicated by noisy breathing or stridor, while complete obstruction is silent. In spontaneously breathing patients, tracheal tug, paradoxical chest and abdominal movement (‘see-saw’ ventilation) and reduced movement of the breathing system’s reservoir bag are other signs. The generation of a large negative intrathoracic pressure during powerful attempts to inhale may cause pulmonary oedema in some patients, particularly young adults. In patients whose lungs are mechanically ventilated, respiratory obstruction may be associated with increased inflation pressure, a prolonged expiratory phase, hypercapnia and alteration of the end-tidal carbon dioxide waveform.

Management: Any significant airway obstruction should be treated by gentle, manual ventilation of the patient’s lungs with oxygen. Location of the site of obstruction should be sought urgently. In the absence of a laryngeal mask airway (LMA) or tracheal tube, apposition of the tongue and pharyngeal soft tissue is a common cause of upper airway obstruction. This may be overcome by a jaw lift or neck extension. It may require the use of an oro- or nasopharyngeal airway, although these devices may themselves provoke laryngospasm or pharyngeal abrasion. Absolute obstruction suggests an equipment problem. Easy passage of a suction catheter through the tracheal tube confirms its patency. If obstruction persists and no obvious cause is identified, then the tracheal tube or laryngeal mask may be the site of obstruction and should be replaced.

Suction removes accumulated secretions in the pharynx, but may cause laryngospasm during light anaesthesia. The presence of symmetrical chest movements and breath sounds should be confirmed. Other causes of obstruction such as laryngospasm, bronchospasm, aspiration and pneumothorax should be excluded.

The most common airway complication is partial respiratory obstruction during spontaneous ventilation or during assisted manual ventilation in the absence of a formal (equipment) airway. A gentle jaw thrust, head tilt and chin lift usually clear a partially obstructed airway, and insertion of an oropharyngeal or nasopharyngeal airway resolves almost all of the remainder. In the rare situation of complete inability to ventilate the patient’s lungs manually, and after equipment failure has been excluded, the insertion of a laryngeal mask airway or tracheal tube may be necessary. Allowing the patient to awaken is prudent if there is no urgency to proceed with the operation. If it is necessary to continue the operation or if the patient cannot be wakened, and insertion of a laryngeal mask airway and tracheal tube have proved impossible, then it becomes necessary to establish a surgical airway. This may take the form of a cricothyroid cannula, a surgical cricothyrotomy or an emergency tracheostomy. These procedures must be learned and practised before the occurrence of the incident. They are technically demanding and are themselves potentially life-threatening to the patient if performed inexpertly (see Ch 22).

Laryngospasm

Laryngospasm is a reflex, prolonged closure of the vocal cords. It occurs usually in response to a trigger, and this is often laryngeal stimulation by airway devices, secretions or gastric contents during light anaesthesia. Laryngospasm is most common during induction and emergence. It may also be produced by surgical and visceral stimuli such as skin incision, peritoneal traction and anal or cervical dilatation. Children are particularly prone to laryngospasm. The use of thiopental inhibits laryngeal reflexes to a lesser extent than propofol and increases the risk of laryngospasm. Poor management of laryngospasm may lead to inadequate ventilation with hypoxaemia, hypercapnia and reduced depth of anaesthesia. Crowing inspiratory noises with signs of respiratory obstruction suggest laryngospasm. Complete obstruction caused by severe laryngospasm is silent.

Management: Where possible, airway and surgical stimulation should be avoided during light anaesthesia and the lateral position should be used for control of secretions during extubation and transfer. Surgical stimuli should be anticipated and anaesthetic depth should be adjusted accordingly. The anaesthetist should remove the stimulus to laryngospasm, administer 100% oxygen and provide a clear airway. Gentle pharyngeal suction should be applied. Where appropriate, anaesthetic depth may be increased by administration of an intravenous anaesthetic agent and the lungs ventilated manually, applying continuous positive airway pressure (CPAP). Most episodes of laryngospasm respond to this treatment. If laryngospasm persists and hypoxaemia ensues, a small dose of succinylcholine (e.g. 25 mg in adults) relaxes the vocal cords and allows manual ventilation and oxygenation. A full dose of succinylcholine may be given if tracheal intubation is indicated, but this is usually unnecessary. Doxapram, an analeptic and respiratory stimulant, has also been used successfully in the treatment of laryngospasm.

Bronchospasm

General anaesthesia may alter airway resistance by influencing bronchomotor tone, lung volumes and bronchial secretions. Patients with increased airway reactivity from recent respiratory infection, asthma, atopy or smoking are more susceptible to bronchospasm during anaesthesia. Bronchospasm may be precipitated by the rapid introduction of a pungent volatile anaesthetic agent (e.g. isoflurane, desflurane), the insertion of an artificial airway during light anaesthesia, stimulation of the carina or bronchi by a tracheal tube or by drugs causing β-blockade or release of histamine. Drug hypersensitivity, pulmonary aspiration and a foreign body in the lower airway may also present as bronchospasm. Bronchospasm causes expiratory wheeze, a prolonged expiratory phase (evident from the upwardly sloping end-tidal carbon dioxide plateau) and increased ventilator inflation pressures. Wheezing may occur in association with other causes of respiratory obstruction, such as pneumothorax, and these should be excluded. If bronchospasm is very severe, ventilation may be quiet and wheeze may not be apparent.

Management: Bronchospasm during anaesthesia results in hypercapnia, hypoxaemia and pulmonary gas trapping, which may cause hypotension (through reduction in left ventricular preload). Management is aimed at preventing hypoxaemia, and resolving the bronchospasm. Initially, 100% oxygen should be given, anaesthesia deepened if appropriate and any aggravating factors removed (e.g. the tracheal tube should be repositioned and surgery stopped). If further treatment is necessary, a bronchodilator should be given in increments according to the response. Recommended drugs include intravenous aminophylline (up to 6 mg kg−1) or salbutamol (up to 3 μg kg−1). Volatile anaesthetic agents and ketamine are also effective bronchodilators. Adrenaline is indicated in life-threatening situations and may be given via the tracheal tube. Steroids and H1-receptor antagonists have no immediate effect but may be indicated in the later management of severe cases of bronchospasm.

If hypoxaemia develops in the spontaneously breathing patient, then tracheal intubation and artificial ventilation should be considered. Mechanical ventilation should incorporate a long expiratory phase to prevent the development of high end-expiratory alveolar pressures, which may cause hypotension, alveolar barotrauma and further hypoventilation. Severe gas trapping (intrinsic PEEP) may result in thoracic hyperexpansion, poor ventilation and pulmonary barotrauma. A very long expiratory phase or disconnection from the ventilator for up to 30 s may be necessary to allow thoracic depressurization. Positive end-expiratory pressure (PEEP) and high ventilatory rates should be avoided if bronchospasm is present because these favour the development of gas trapping. Hypercapnia may have to be tolerated in order to avoid gas trapping and barotrauma.

Complications Associated with Tracheal Intubation

Difficult Intubation

Some difficulty is experienced during tracheal intubation in about one in ten patients (10%). Approximately one in ten of these patients (1%) presents significant difficulty in intubation. Intubation is impossible in about one in ten of these patients (0.1%), and both intubation and ventilation are impossible in about one in ten of these (0.01%). In most instances, the cause of difficulty with the airway is difficulty in attaining an adequate view of the laryngeal inlet at laryngoscopy.

Poor management of difficult intubation is a significant cause of morbidity and mortality during anaesthesia. Sequelae include dental and airway trauma, pulmonary aspiration, hypoxaemia, brain damage and death. Table 43.2 shows the commonest causes of difficulty in intubation. The single most important cause is an inexperienced or inadequately prepared anaesthetist and the difficulty is often compounded by equipment malfunction. The anatomical features associated with difficult laryngoscopy are listed in Table 43.3. Of these, the atlanto-occipital distance is the best predictor of difficulty but requires a lateral cervical X-ray. Many of these factors are normal anatomical variations, but extreme abnormalities do occur. A cluster of normal variations in an apparently healthy patient may be sufficient to cause major difficulties in laryngoscopy.

TABLE 43.3

Anatomical Factors Associated with Difficult Laryngoscopy

Short, wide, muscular neck

Protruding incisors

High, arched palate

Receding lower jaw

Poor mobility of the mandible

Increased anterior depth of mandible

Increased posterior depth of mandible (reduces jaw opening, requires X-ray)

Decreased atlanto-occipital distance (reduces neck extension, requires X-ray)

Management: Preoperative examination of the airway (Table 43.4) is essential. Identification of patients with a potentially difficult airway (see Tables 43.2 and 43.3) before anaesthesia allows time to plan an appropriate anaesthetic technique. The Mallampati test is a widely used and simple classification of the pharyngeal view obtained during maximal mouth opening and tongue protrusion (see pp. 455–456). In practice, this test suggests a higher likelihood of difficult laryngoscopy if the posterior pharyngeal wall is not seen. The predictive value of this test may be strengthened if the thyromental distance (the distance between the thyroid cartilage prominence and the bony point of the chin during full head extension) is less than 6.5 cm.

TABLE 43.4

Preoperative Assessment of the Airway

General appearance of the neck, face, maxilla and mandible

Jaw movement

Head extension and neck movement

Teeth and oropharynx

Soft tissues of the neck

Recent chest and cervical spine X-rays

Previous anaesthetic records

Mallampati classification

Thyromental distance

Premedication with an antisialagogue reduces airway secretions. This is advantageous before inhalational induction and essential for awake fibreoptic laryngoscopy to maximize the effectiveness of topical local anaesthesia. An anxiolytic may also be given (but is contraindicated in patients with airway obstruction, e.g. caused by burns, trauma, tumour or infection affecting the larynx or pharynx). The presence of a trained assistant is essential and the availability of an experienced anaesthetist and a ‘difficult intubation’ trolley with a range of equipment such as bougies, a variety of laryngoscopes and tracheal tubes, and cricothyrotomy needles is desirable (see Ch 22).

A variety of options exists for the patient in whom a difficult laryngoscopy is anticipated. If the procedure can be carried out under local or regional anaesthesia, then this technique should be used as the first choice (see Ch 24). However, the patient, anaesthetist and equipment must be prepared for general anaesthesia in case a complication arises.

If general anaesthesia is necessary for the procedure, or if the patient refuses local or regional anaesthesia despite a frank discussion of the risks, then steps must be taken to secure the airway safely. Unless tracheal intubation is essential for airway protection or to enable muscle relaxation and ventilation, the use of an artificial airway such as the laryngeal mask with spontaneous ventilation is usually a safe technique. If intubation is essential, the appropriate anaesthetic technique depends on the anticipated degree of difficulty, the presence or absence of airway obstruction and the risk of regurgitation of gastric fluid. The management of the patient in whom difficulties with airway management are anticipated is detailed in Ch 22.

There is no place for the use of a long-acting muscle relaxant to facilitate tracheal intubation if difficulty is anticipated. Correct positioning of the head and neck is essential and the lungs should be denitrogenated after establishing intravenous access and appropriate monitoring.

The safest anaesthetic technique may usually be chosen from the following clinical examples.

1. Patients with an increased risk of regurgitation and aspiration (e.g. full stomach, intra-abdominal pathology, pregnancy). An inhalational induction is inappropriate in these patients. Regional anaesthesia is preferable in the parturient (see Ch 35). Preoxygenation and a rapid sequence induction with succinylcholine can be used if there is little anticipated difficulty. If intubation is unsuccessful, no further doses of neuromuscular blocking drug should be used, the patient allowed to wake and further assistance sought. If there is a high degree of anticipated difficulty, an awake technique is recommended (see below).

2. Patients with little anticipated difficulty and no airway obstruction (e.g. mild reduction of jaw or neck movement). After a sleep dose of intravenous induction agent and confirmation of the ability to ventilate the lungs manually by mask, succinylcholine may be given to provide the best conditions for tracheal intubation. If difficulty is encountered, the patient is allowed to wake up and the procedure replanned. Where appropriate, anaesthesia is deepened by spontaneous ventilation using a volatile agent and alternative techniques to facilitate tracheal intubation used (see Ch 22).

3. Patients with severe anticipated difficulty and no airway obstruction (e.g. severe reduction of jaw or neck movement). Appropriate techniques include inhalational induction with sevoflurane or the use of fibreoptic laryngoscopy either in the awake patient or after inhalational induction. Neuromuscular blocking drugs must not be used until the ability to ventilate the lungs manually and view the vocal cords is confirmed.

4. Patients with airway obstruction (e.g. burns, infection, trauma). An inhalational induction may be used; otherwise an awake technique should be considered. Neuromuscular blocking drugs should not be used until tracheal intubation is confirmed.

5. Extreme clinical situations. Tracheostomy performed under local anaesthesia may be the safest technique.

Inhalational Induction

Premedication with an antisialagogue is desirable. Depth of anaesthesia is increased carefully by spontaneous ventilation of increasing concentrations of a volatile anaesthetic agent in 100% oxygen until laryngoscopy may be performed safely. Sevoflurane currently provides the best conditions for this purpose. If the larynx is viewed easily, intubation may be performed with or without a muscle relaxant. If the view is limited, a suitable bougie may be inserted to assist passage of the tracheal tube through the larynx. Correct insertion of the bougie in the trachea may be confirmed by detecting the palpable bumps of the tracheal rings or resistance when the carina is encountered. The tracheal tube is then passed over the bougie into the trachea. This manoeuvre is facilitated by rotating the tracheal tube 90° as it passes through the glottis. If intubation during direct laryngoscopy is unsuccessful, anaesthesia may be maintained and the use of fibreoptic laryngoscopy, blind nasal intubation or a retrograde technique considered.

Failed Intubation

The total incidence of failed tracheal intubation is approximately 1 in 1000 (0.1%), but about 1 in 300 (0.3%) in obstetric patients. However, failed intubation in obstetric patients is now a rare event because of the high percentage of obstetric surgical patients operated on under regional anaesthesia.

Most failed intubations result from the anaesthetist failing to insert the tube, but occasionally the tube may be misplaced, most commonly in the oesophagus. This complication has resulted in many deaths since the advent of tracheal intubation. It should be suspected whenever difficulty has been experienced in inserting a tracheal tube, particularly when direct visual confirmation of the passage of the tube into the larynx has not been possible. Auscultation of the chest is recommended, although inflation of the stomach may occasionally mimic breath sounds. Auscultation over the stomach usually detects a bubbling sound if the oesophagus has been intubated.

Observation of a normal capnogram usually provides assurance of tracheal placement of the tube, but cases have been described of patients who have ‘expired’ carbon dioxide briefly despite oesophageal intubation, having ingested carbonated drinks or bicarbonate antacids shortly before anaesthesia. A normal and persistent expiratory capnogram should be sought as confirmation of tracheal tube placement.

Fibreoptic bronchoscopy provides an excellent method of assuring the location of the tube, but is not usually available in every operating theatre. The ‘Wee’ oesophageal intubation detector tests for the free aspiration of air via the tracheal tube into a rubber bulb. The device is cheap, easy to use and accurate, but total reliance should not be placed on this device. The capnogram is the ‘gold standard’ for confirming correct tracheal intubation.

Poor management of failed intubation is a significant cause of serious morbidity and mortality. The aims of management are to maintain oxygenation and prevent aspiration of gastric contents. The ‘failed intubation drill’ is now established as an important skill for safe anaesthetic practice. An early decision to use a failed intubation protocol and to call for assistance is essential, because continued attempts at tracheal intubation may result in trauma to the airway, pulmonary aspiration or hypoxaemia (see Ch 22). The obstetric patient is a special case and is considered in Chapter 35.

If the airway is obstructed and ventilation is inadequate during management of a failed intubation, then insertion of an LMA should be considered (see Figs 22.322.5). It has been used successfully to provide an airway and allow ventilation when attempts to intubate the trachea and ventilate the lungs by other means have failed. Alternatively, it may be possible to pass a small-diameter tracheal tube or a bougie through the LMA into the trachea; a variant of the LMA, the intubating LMA (ILMA) is designed specifically to facilitate tracheal intubation. The LMA should not be regarded as providing protection against pulmonary aspiration, although it is claimed that the ProSeal™ LMA, which has a rearward port for the downward passage of a gastric tube or the upward passage of gastric contents, is better in this regard. The oesophageal obturator airway and similar devices are alternatives in an emergency, but there are doubts about their efficacy and there have been reports of misplacement and oesophageal rupture associated with their use. A recent innovation is an ILMA which incorporates a video camera and LCD screen, allowing direct visualization of the introduction of a tracheal tube through the larynx.

When consciousness cannot be restored rapidly for pharmacological reasons, then transtracheal ventilation can be life-saving. A cannula or small-diameter tracheal tube may be passed via the cricothyroid membrane. Ventilation through a cannula requires high-pressure, ‘jet’ ventilation from a Sanders injector or the high-pressure oxygen outlet of the anaesthetic machine. More conventional ventilation is possible through a small-diameter tube placed via the cricothyroid membrane, but the procedure, which requires a transcutaneous scalpel incision, requires some practice and may result in haemorrhage. Both techniques allow adequate oxygenation for many minutes, and should provide time to allow the patient to awaken. Exhalation through a cricothyroid cannula may be inadequate, and if the laryngeal inlet is not patent then inadequate ventilation and barotrauma may result. In this situation, an additional cannula should be inserted to allow gas to escape.

If it is essential that surgery proceeds without the patient awakening then oxygenation and carbon dioxide elimination must be maintained while ensuring an adequate depth of anaesthesia. Any of the rescue techniques described above may be used, but usually the laryngeal mask or the fibreoptic bronchoscope prove most useful.

Aspiration of Gastric Contents

Regurgitation of gastric contents is common during anaesthesia. Frequently, regurgitation proceeds only as far as the mid-oesophagus, but occasionally gastric contents enter the oropharynx. This is particularly likely in patients with a hiatus hernia or a full stomach. The latter may result from recent eating or drinking or may be the result of gastric outlet or bowel obstruction, pain, stress or drugs which delay gastric emptying, such as morphine and alcohol. Once gastric contents enter the oropharynx, there exists the potential for aspiration into the lungs. This is uncommon, but remains an important cause of morbidity and mortality associated with anaesthesia. Aspiration of oropharyngeal contents is more likely if those contents are allowed to remain in the oropharynx for a significant time, and if laryngeal reflexes are depressed. Aspiration may occur also in the sedated patient, whose laryngeal reflexes are diminished. Aspiration is more common during difficult intubation, emergency cases and in obese or pregnant patients.

Mortality is high after aspiration of large quantities of gastric contents and the aspiration of solids, in particular, is associated with a poor prognosis. The acidity of gastric contents is also important in determining the degree of severity of the pulmonary reaction to aspiration, with highly acid material being particularly inflammatory. Bronchospasm may be the first sign of pulmonary aspiration during general anaesthesia. If a large quantity of gastric material is aspirated, respiratory obstruction, ventilation–perfusion mismatch and intrapulmonary shunting may produce severe hypoxaemia, with later development of chemical pneumonitis and/or infection.

Management: At-risk patients should be managed actively to prevent the aspiration of gastric contents. The volume and acidity of the gastric contents should be reduced as far as possible. Preoperative fasting, histamine H2-receptor blockers and a gastric prokinetic drug (e.g. metoclopramide) are recommended. If general anaesthesia is essential, then the trachea must be intubated. Most commonly, this is achieved using a rapid-sequence induction with cricoid pressure (see Ch 37), but awake intubation is advisable if difficulty in intubation is predicted. During emergence, the tracheal tube should not be removed until protective airway reflexes are regained when the patient is awake.

If aspiration occurs during anaesthesia, further regurgitation should be prevented by immediate application of cricoid pressure, and the patient should be placed in a head-down position. The left lateral position should also be considered to encourage the drainage of gastric contents out of the mouth. In all but the mildest cases, the trachea should be intubated to facilitate removal of the aspirated material by suction before the use of positive-pressure ventilation. However, ventilation should not be delayed if significant hypoxaemia is present. Bronchodilator therapy may be required and the inspired oxygen concentration should be increased. Positive end-expiratory pressure may be used if hypoxaemia is refractory to increasing inspired oxygen fraction. Non-emergency surgery should be abandoned if significant morbidity develops. Flexible bronchoscopy permits the removal of liquids, although rigid bronchoscopy may be necessary for the removal of solid matter. Intravenous steroids and pulmonary lavage with saline via a flexible bronchoscope may reduce the post-aspiration inflammatory response. A chest X-ray and arterial blood gas measurement help in the assessment of the severity of injury. The patient should be transferred to a critical care unit for further monitoring and respiratory care.

Hypoxaemia

Hypoxaemia is an inadequate partial pressure of oxygen in arterial blood. Hypoxia is oxygen deficiency at the tissue level. A practical classification of the causes of hypoxaemia is shown in Table 43.5. Hypoxaemia threatens tissues globally and, if allowed to persist, risks permanent damage to those organs most delicately dependent upon continued oxygen supply. The first organs to be damaged, most commonly, are the brain and heart, and any pathological impairment of their blood supply increases the risk of early and permanent damage. There is no categorically safe or unsafe level of arterial oxygen tension (PaO2). The risk presented by a level of hypoxaemia is dependent upon the patient’s haemoglobin concentration, cardiac output, state of hydration, concurrent disease processes (especially vasculopathic diseases) and the duration of exposure to the lowered PaO2. In general, few patients are harmed by arterial oxyhaemoglobin saturations of greater than 80%, but clearly, this low level provides very little margin for safety should any other complication occur. Most anaesthetists choose to set the arterial oxygen saturation alarm limits on the pulse oximeter at 92–94%.

Severe hypoxaemia produces tachycardia, sweating, hypertension and arrhythmias, although bradycardia is the commoner response in children. Tachypnoea occurs in spontaneously breathing patients. There may also be clinical signs associated with the cause. As arterial desaturation progresses, bradycardia and hypotension (caused by myocardial depression) develop. Eventually, cardiac arrest occurs, usually in asystole. By this stage, the heart, brain, kidneys and liver may have incurred irreversible ischaemic damage.

Hypoventilation is very common during anaesthesia, but in the presence of an adequate inspired oxygen concentration (i.e. over 30%) must be very severe to cause hypoxaemia. Reduction of the ventilatory minute volume from a normal value of 5 L min−1 to 2 L min−1 in the presence of an inspired oxygen concentration of 30% causes arterial oxygen saturation to decrease to only around 90% in an otherwise healthy patient. This represents severe hypoventilation, and produces an arterial carbon dioxide tension of approximately 13 kPa. The pulmonary shunting and atelectasis that can occur during anaesthesia are much more likely to cause hypoxaemia than is hypoventilation.

Management: Hypoxaemia occurring during anaesthesia is almost invariably treatable and its complications are preventable. Cyanosis should seldom be witnessed by the vigilant anaesthetist because the routine use of pulse oximetry allows early detection and treatment of hypoxaemia. If hypoxaemia is detected, the following drill should be instituted.

1. A-B-C. Ensure an adequate airway, ensure adequate ventilation and check for an adequate cardiac output by feeling the carotid pulse.

2. Exclude delivery of a hypoxic gas mixture using an oxygen analyser. Increase the inspired oxygen concentration to 100%.

3. Test the integrity of the breathing system by manual ventilation of the lungs and confirm bilateral chest movement and breath sounds. Blow down the tracheal tube if necessary.

4. Confirm the position and patency of the tracheal tube by assessing the capnogram, passing a suction catheter through the tracheal tube and auscultating the chest.

5. Search for clinical evidence of the causes of imagemismatch with early exclusion of pneumothorax. If atelectasis or reduced functional residual capacity (FRC) is contributory, gentle hyperinflation of the lungs should improve oxygenation. Lung volume may be maintained by applying PEEP.

6. If the diagnosis is difficult, measure core temperature, and consider arterial blood gas analysis and chest X-ray examination.

Apnoea

Apnoea occurs during most anaesthetics. It is eminently treatable, and usually results in no harm to the patient. The occurrence of hypoxaemia, hypercapnia and acidaemia are predictable consequences of prolonged apnoea. The development of hypoxaemia after induction of anaesthesia is often delayed by preoxygenation of the patient’s lungs. However, when hypoxaemia becomes evident, it progresses swiftly and inexorably unless oxygenation of the lungs is restored. Rapid progression of hypoxaemia occurs in the presence of airway obstruction, high oxygen consumption and small FRC. Such factors may appear in combination in small children, pregnancy and obesity. Carbon dioxide is retained during apnoea, and PaCO2 increases by 0.4–0.8 kPa min−1, while arterial pH decreases by approximately 1.5 h−1 or 0.025 min−1. Atelectasis develops quickly during apnoea under anaesthesia, particularly in obese patients.

As a consequence of its water solubility, very little carbon dioxide enters the lungs during apnoea and the net flow of ambient gas through an open airway and into the alveoli is very nearly equal to the rate of oxygen consumption (i.e. 250 mL min−1). Consequently, adequate oxygenation may be assured for many minutes by the provision of 100% oxygen to the open airway during apnoea. If the airway is obstructed then this mass flow cannot occur and hypoxaemia develops much more quickly. In addition, the intrathoracic pressure may become significantly hypobaric if the airway is obstructed, and this further reduces the alveolar and arterial oxygen tensions.

Management: Unless required for surgery (e.g. during cardiopulmonary bypass or delicate lung surgery), apnoea should not be allowed to persist untreated. Significant atelectasis, hypercapnia and acidaemia may develop silently. If atelectasis develops, then recruitment manoeuvres may be successful in reversing it (see p. 867).

The development of hypoxaemia during apnoea is greatly slowed by the provision of 100% oxygen to an open airway. Therefore, it is mandatory that periods of apnoea (e.g. during rapid-sequence induction) are accompanied by an airway open to a breathing system supplying 100% oxygen. This is of particular importance during periods of high oxygen consumption (e.g. during fasciculations associated with administration of succinylcholine). Following the rescue of an obstructed airway, there is a rapid influx of ambient gas into the previously hypobaric thorax. Provision of 100% oxygen at this point may significantly restore depleted oxygen reserves and arterial oxygen saturation.

Hypercapnia

Hypercapnia is an abnormally high partial pressure of carbon dioxide in arterial blood (PaCO2). Typically, this is indicated by a PaCO2 greater than 6 kPa. Hypercapnia is caused by either inadequate carbon dioxide removal (e.g. caused by hypoventilation or increased pulmonary dead space) or excessive carbon dioxide production. During anaesthesia, hypercapnia may also result from an inadequate fresh gas flow rate into a semiclosed anaesthetic breathing system, or by exhausted carbon dioxide absorbent in a circle system, resulting in rebreathing of carbon dioxide.

Carbon dioxide production increases during pyrexia, malignant hyperthermia and shivering. Inadvertent or excessive carbon dioxide delivery from the anaesthetic machine and absorption of carbon dioxide during laparoscopic procedures are other causes of hypercapnia.

Hypercapnia stimulates activity of the sympathetic nervous system and causes tachycardia, sweating and arrhythmias (usually ectopics or tachyarrhythmias), increased cerebral blood flow, increased intracranial pressure, tachypnoea and alterations in arterial pressure. As anaesthetic drugs suppress autonomic responses, these signs may not occur during anaesthesia until PaCO2 is markedly increased. Acute respiratory acidosis produces an increase in serum potassium concentration.

Hypocapnia

Hypocapnia is an abnormally low PaCO2 (less than 4.5 kPa). The most common cause is mechanical hyperventilation. Decreased carbon dioxide production may occasionally be responsible if the patient is cold or deeply anaesthetized. Hypocapnia produces respiratory alkalosis with a decrease in serum potassium concentration. There is generalized vasoconstriction and reductions in cerebral blood flow, cardiac output and tissue oxygen delivery. Patients with critical cerebrovascular stenosis may risk cerebral ischaemia, but otherwise hypocapnia tends not to produce significant morbidity. There may be a delay in onset of spontaneous ventilation at the conclusion of anaesthesia in which mechanical ventilation has been used while PaCO2 increases to levels which stimulate ventilation.

Management: Decreasing the ventilatory minute volume or increasing the breathing system dead space reduce removal of carbon dioxide from the blood. It is important to note that the most accessible representation of PaCO2 currently available to anaesthetists is the end-tidal carbon dioxide tension (PE’CO2). This is usually approximately 0.5–1.0 kPa less than PaCO2 but this gap varies significantly with the site of sampling of expired gas and with variations in the alveolar dead space fraction. The latter is affected by alterations in arterial pressure, cardiac output, posture and tidal volume. The anaesthetist should not assume, therefore, that a low value of end-tidal carbon dioxide tension necessarily reflects a low PaCO2. Such an assumption could result in significant hypoventilation if the minute volume is reduced inappropriately.

Pneumothorax

The causes of pneumothorax include trauma, central venous cannulation especially via the subclavian route, brachial plexus blockade, cervical and thoracic surgery, and barotrauma. Occasionally, pneumothorax may develop spontaneously in patients with asthma, chronic obstructive pulmonary disease, congenital cystic pulmonary disease or Marfan’s syndrome. During anaesthesia, very high mechanically generated peak inspiratory airway pressures greatly increase the risk of pulmonary barotrauma and pneumothorax. Patients with recent chest trauma, asthma or chronic lung disease (particularly with bullae) are most at risk. Pneumothorax significantly reduces ventilation of the affected lung with resultant carbon dioxide retention. Simultaneously, pulmonary shunting often occurs, with resultant hypoxaemia.

Nitrous oxide diffuses into air-filled spaces more rapidly than nitrogen diffuses out, and causes pneumothoraces to expand. Mechanical ventilation forces gas into the pleural space if the lung has been punctured, with a rapid increase in the size of the pneumothorax. Increasing imagemismatch and hypoxaemia follow. If the pneumothorax is under tension, hypoxaemia, mediastinal shift, reduced venous return and impairment of cardiac output may be life-threatening. A pneumothorax should be excluded during anaesthesia if unexplained tachycardia, hypotension, hypoxaemia, hypoventilation (in the spontaneously breathing patient) or high inflation pressures (in the ventilated patient) occur intraoperatively. Examination may reveal unequal air entry, asymmetrical chest movement, wheeze, surgical emphysema, elevated jugular or central venous pressure, or mediastinal shift. Chest X-ray examination provides a definitive diagnosis, but treatment should not be delayed for this investigation if severe hypoxaemia or hypotension exist and a pneumothorax is suspected.

Management: If pneumothorax is suspected prior to anaesthesia, then it should be excluded by chest X-ray. A chest X-ray should be performed preoperatively in all patients who have suffered recent chest trauma and in those in whom a central venous catheter has recently been inserted. Occasionally a chest X-ray fails to show a small pneumothorax which may expand rapidly with the use of nitrous oxide and positive-pressure ventilation. In patients with recent chest trauma, including rib fractures, regional analgesia may be the preferred technique. If tracheal intubation and mechanical ventilation are required in a patient with a pneumothorax, a chest drain should be inserted before induction of anaesthesia. If there is a chest drain in situ, its patency and position should be checked before induction of anaesthesia.

If a pneumothorax is suspected intraoperatively, treatment should not be delayed to confirm the diagnosis by chest X-ray examination. Administration of nitrous oxide should be discontinued and the lungs ventilated with 100% oxygen, using low inflation pressures. The presence of air in the pleural space may be confirmed by careful aspiration through an intravenous cannula inserted through the chest wall on the suspected side via the second intercostal space in the mid-clavicular line or in the fifth space in the mid-axillary line. If the pneumothorax is under tension, there may be a hiss as air is released. Temporary decompression using one or more large intravenous cannulae may be life-saving. If a pneumothorax is confirmed, the intravenous cannula should be left in place while a formal chest drain is inserted.

The presence of a bronchopleural fistula with substantial air leak may make ventilation ineffective. In this situation, hypoventilation ensues, resulting in carbon dioxide retention. A tension pneumothorax may result. The affected lung may be isolated by insertion of a bronchial tube (either single- or double-lumen) or gas exchange improved by the use of high-frequency ventilation. A chest drain allows decompression of the pneumothorax.

Atelectasis

The reduction in functional residual capacity and the tendency to hypoventilation which occur during general anaesthesia make alveolar collapse, or atelectasis, common. Atelectasis causes impairment of gas exchange and increases the risk of postoperative chest infection. Risk factors for its development include pre-existing lung disease, lengthy anaesthesia, spontaneous ventilation, high abdominal pressures, high inspired oxygen fractions and the head-down position. Extended exposure of the open airway to atmospheric pressure adds significantly to the risk of alveolar collapse. In particular, prolonged apnoea during anaesthesia (e.g. while awaiting the onset of spontaneous ventilation) causes atelectasis.

Management: Atelectasis may be reduced through the use of mechanical ventilation during lengthy operations, the incorporation of nitrogen into the inspired gas mixture, the use of a head-up position where possible and the use of PEEP during mechanical ventilation or continuous positive airways pressure (CPAP) during spontaneous ventilation. If atelectasis is suspected (usually through observation of a gradual downward drift in arterial oxygen saturation or a gradual increase in peak inspiratory pressure during mechanical ventilation), several gentle manual hyperinflations of the lungs usually re-inflate the collapsed alveoli (alveolar recruitment) and result in an increase in arterial oxygen saturation. Inflation for up to 20 s at 40 cmH2O is often required for a successful recruitment manoeuvre. Such a recruitment manoeuvre is probably best performed using a mechanical ventilator.

If atelectasis becomes established during general anaesthesia, then the patient is at increased risk of pulmonary dysfunction postoperatively. In this situation, the provision of good analgesia (to encourage coughing and mobilization), use of the sitting position and physiotherapy reduce postoperative morbidity.

Cardiovascular Complications

Hypertension

Intraoperative hypertension may be defined as an arterial pressure (systolic, mean or diastolic) 25% greater than the patient’s preoperative value. Systolic hypertension increases myocardial work by increasing afterload and left ventricular wall tension. It is often associated with tachycardia, which places additional metabolic demands on the myocardium. Patients with ischaemic heart disease or left ventricular hypertrophy may be placed at risk of myocardial ischaemia or infarction. Chronic hypertension is associated with impaired organ perfusion through atherosclerosis. Acute intraoperative hypertension increases the risks of ischaemia, infarction and haemorrhage in other organs, and in particular, the brain.

Table 43.6 shows the commonest causes of hypertension during anaesthesia. In the absence of pre-existing hypertension, the majority of instances of intraoperative hypertension are related to increased activity of the sympathetic nervous system. This may be associated with tachycardia and arrhythmias. The commonest causes of hypertension are inadequate analgesia, light anaesthesia, surgical stimulation and airway manipulation. Drug administration errors are probably under-recognised underlying causes. However, all instances of intraoperative hypertension must prompt exclusion of awareness and malignant hyperthermia as the cause.

TABLE 43.6

Causes of Hypertension During Anaesthesia

Pre-Existing

Undiagnosed or poorly controlled hypertension

Pregnancy-induced hypertension

Withdrawal of antihypertensive medication

Increased Sympathetic Tone

 Inadequate analgesia

 Inadequate anaesthesia

Hypoxaemia

 Airway manipulation (laryngoscopy, extubation)

Hypercapnia

Drug Overdose

Vasoconstrictors (noradrenaline, phenylephrine)

Inotropes (dobutamine)

Mixed inotropes/vasoconstrictors (adrenaline, ephedrine)

Ketamine

Ergometrine

Other

Aortic cross-clamping

Phaeochromocytoma

Malignant hyperthermia

Management: Preoperative preparation reduces the incidence of unexpected intraoperative hypertension. Adequate pharmacological treatment of chronic hypertension is essential. Poorly controlled chronic hypertension may result in exaggerated vascular responses during anaesthesia and these patients may suffer greater intraoperative and postoperative morbidity and mortality from arrhythmias and myocardial ischaemia. A calm, relaxed patient is less likely to experience intraoperative hypertension, so consideration should be given to anxiolytic premedication. Where possible, surgery should be postponed until adequate control is achieved (e.g. arterial pressure less than 180/110 mmHg) and organ function (e.g. heart and kidneys) assessed. If end-organ damage is found, it should be investigated, treated and the perioperative risk re-assessed. In the absence of such damage, anaesthesia and surgery can usually proceed. There is some evidence that beta blockade, alpha2 agonists or thoracic epidural block may aid cardiovascular stability.

Stimulating events during anaesthesia and surgery cause surges in sympathetic tone, with significant increases in arterial pressure. These events may usually be anticipated and a short-acting opioid (e.g. alfentanil 10 μg kg−1), β-blocker (e.g. esmolol 0.5 mg kg−1), lidocaine (1 mg kg−1) or temporary deepening of the anaesthetic may be used to obtund potentially damaging hypertension. Such events include laryngoscopy, surgical incision, extubation and aortic cross-clamping. Hypertension which occurs despite normoxaemia, adequately deep anaesthesia and adequate analgesia should prompt the exclusion of the causes listed in Table 43.6. If no pathological cause is found, the use of an antihypertensive agent such as labetalol or hydralazine may be indicated. The effect of negatively inotropic and vasodilating drugs is potentiated by anaesthetic agents, so careful titration is required.

Hypotension

During anaesthesia, hypotension is usefully defined as a mean arterial pressure 25% less than the patient’s usual, resting value. Hypotension may impair perfusion and, consequently, oxygenation of vital organs. During anaesthesia, myocardial and cerebral metabolic rates are reduced significantly, and intraoperative hypotension is less likely to cause permanent damage to these organs than would be the case in the conscious state. However, pathological processes (e.g. atherosclerosis) commonly compromise the arterial supply to organs, and hypotension during anaesthesia occasionally results in critical loss of flow to vital organs. Left ventricular coronary artery flow occurs predominantly in diastole, and diastolic arterial pressure is particularly important in determining myocardial viability in patients with ischaemic heart disease.

Hypotension is caused by decreases in cardiac output or systemic vascular resistance. Table 43.7 shows the common causes of intraoperative hypotension. Most anaesthetic agents cause vasodilatation and have a negative inotropic effect, and moderate hypotension is very common during anaesthesia, particularly before the start of surgery when there is no physical stimulation to counteract the effects of anaesthetic drugs. Concurrent hypovolaemia caused by preoperative fluid restriction, in combination with haemorrhage or concurrent antihypertensive drugs, may result in decreases in mean arterial pressure during anaesthesia and surgery. A mean arterial pressure of 50 mmHg or less is potentially damaging, even in healthy individuals, and should not be allowed to persist. The patients most at risk from the effects of hypotension are, unfortunately, often the patients most likely to develop it because of concurrent medications, poor myocardial reserve and atherosclerosis. Elderly or hypertensive patients should, therefore, be observed carefully for the development of hypotension, and it should be treated promptly.

Management: Preoperative correction of hypovolaemia helps to avoid excessive reduction in arterial pressure following induction of anaesthesia. The cardiovascular effects of anaesthetic agents are predictable, and judicious doses of drugs should be used.

Artefactual measurements are not uncommon when using oscillometric devices to measure arterial pressure. If intraoperative hypotension occurs and the measurement is validated, then a working diagnosis should be established and treatment should be commenced, aimed at correcting the cause of the hypotension. Most commonly, this involves administering intravenous fluids or decreasing the concentration or infusion rate of anaesthetic agents, although care must be taken to ensure delivery of sufficient anaesthetic agent to avoid awareness. This treatment is effective in most patients. Persistent hypotension, where significant pathological causes (e.g. arrhythmia, anaphylaxis, concealed haemorrhage or pneumothorax) have been excluded, may be treated with a cautious dose of a vasopressor agent (e.g. ephedrine 5 mg or metaraminol 1 mg). Treatment of hypotension should follow the sequence of assess → treat → re-assess. Unexpected responses to treatment should prompt a re-evaluation of the diagnosis and suspected aetiology.

Hypovolaemia

Hypovolaemia is a common intraoperative cause of hypotension. Its common aetiologies are listed in Table 43.8. The additive effects of anaesthesia, positive-pressure ventilation and hypovolaemia may cause sudden and severe hypotension, which may be life-threatening. All patients who are undergoing surgery, and in particular patients who require emergency surgery, should be assessed preoperatively with regard to intravascular fluid volume and fluid balance. Signs of hypovolaemia include thirst, dryness of mucous membranes, cool peripheries, oliguria (urine output < 0.5 mL kg−1 h−1), reduced tissue turgor, tachycardia and postural hypotension. Patients treated with a β-blocking drug may not develop a compensatory tachycardia despite being hypovolaemic. Fluid deficit and replacement are easily underestimated, especially in patients with intestinal obstruction or concealed haemorrhage. Surgery, unless immediately life-saving, should be delayed to allow adequate fluid resuscitation and restoration of intravascular volume. The response of central venous pressure (CVP) to fluid challenges is a useful guide when assessing and treating patients with significant hypovolaemia. Hypokalaemia and other electrolyte abnormalities are often associated with fluid deficits, particularly when there have been gastrointestinal losses.

TABLE 43.8

Causes of Hypovolaemia and Fluid Loss

Preoperative

Haemorrhage

 Trauma

 Obstetric

 Gastrointestinal

 Major vessel rupture (aortic aneurysm)

Gastrointestinal

 Vomiting

 Obstruction

 Fistulae

 Diarrhoea

Other

 Fasting

 Diuretics

 Fever

 Burns

Intraoperative

Haemorrhage

Insensible loss

 Sweating

 Expired water vapour

Third-space loss

 Prolonged procedures

 Extensive surgery

 Prolonged retraction

Drainage of stomach, bowel, or ascites

In the presence of hypovolaemia, hypotension after induction of anaesthesia is often exaggerated in the elderly and in patients with decreased cardiac reserve or pre-existing hypertension. It is made less likely by fluid preloading and by titration of the induction agent to effect. Etomidate and ketamine produce less cardiovascular depression than do other induction agents.

Blood loss during surgery may be concealed. The anaesthetist must note carefully the total loss in suction jars, swabs and spillage. Body water is lost during anaesthesia and surgery in urine, sweat and exhaled breath. Adequate intraoperative fluid replacement must account for all of these losses. During abdominal surgery, up to 5 mL kg−1 h−1 may be required to replace evaporative and third-space losses in addition to maintenance requirements and replacement of blood loss.

Haemorrhage

Haemorrhage is the loss of blood and is inevitable during most forms of surgery. Loss of a significant proportion of the total intravascular volume threatens the patient’s well-being. Hypovolaemia causes reduced tissue perfusion, while loss of red cell mass causes reduced oxygen carriage in arterial blood. There is no safe degree of haemorrhage, in that patients differ in their ability to tolerate blood loss. Anaemic or hypovolaemic patients are less able to compensate for haemorrhage than healthy patients. Patients with pre-existing compromise of vital organ perfusion (e.g. patients with diabetes mellitus or hypertension) suffer deleterious consequences of haemorrhage sooner than healthy patients. In general, adults who have lost 15% of circulating blood volume may require red blood cell transfusion to maintain oxygen-carrying capacity.

Blood loss can be estimated by weighing swabs, measuring the volume of blood in suction bottles and assessing the clinical response to fluid therapy. Estimation is often difficult if large volumes of irrigation fluid have been used, e.g. during transurethral resection of the prostate. Intraoperative measurement of haemoglobin concentration aids estimation of blood loss and guides therapy. With severe or ongoing haemorrhage, maintenance of intravascular volume is essential. When the cardiac output is preserved, very severe anaemia is often well tolerated for short periods, but low tissue blood flow in the presence of anaemia may produce rapid and irreversible organ damage.

Massive blood loss may require the administration of stored blood, fresh frozen plasma, clotting factors and electrolytes. The problems of massive transfusion are discussed in Chapter 13.

Disturbances of Heart Rate

Bradycardia: Bradycardia is commonly defined as a heart rate less than 60 beat min−1. Heart rate very commonly decreases during anaesthesia because much afferent input is lost and because many anaesthetic agents and opioids have parasympathomimetic actions. Surgical manipulations such as traction on the eye, cervical or anal dilatation and peritoneal traction may increase vagal tone, producing bradycardia and occasionally sinus arrest. Several drugs may cause bradycardia. Succinylcholine may produce a profound decrease in heart rate, especially following repeat doses. Bradycardia occurs in some patients after intravenous injection of rapidly acting opioid analgesics such as remifentanil, alfentanil and fentanyl. There have been several reports of profound bradycardia in association with the use of propofol. Finally, neostigmine and β-blockers may cause profound bradycardia. Anaesthesia-induced bradycardia often leads to an escape rhythm, with a wandering suprajunctional pacemaker. Hypothermia and hypothyroidism can also cause bradycardia.

Bradycardia reduces cardiac output, although the longer diastolic filling time and lower afterload may result in a larger ejection fraction. Diastolic pressure usually decreases and, consequently, myocardial perfusion is reduced. The concurrent reduction in myocardial oxygen demand protects against myocardial ischaemia, and myocardial damage caused by bradycardia is very rare. However, other organs may suffer; in particular, the brain, kidneys and liver may become ischaemic if a very low heart rate is allowed to persist.

Management. Healthy patients usually tolerate a heart rate of 30 beat min−1 without organ damage. Patients with impaired organ perfusion or impaired oxygen carriage may not tolerate such low heart rates well. The risk of sinus arrest or asystole is heightened at this low rate, and most anaesthetists treat bradycardia if the heart rate decreases to 40 beat min−1 or less. Bradycardia becomes particularly significant if associated with significant hypotension. Bradycardia may be treated by administration of an anticholinergic, antimuscarinic agent such as glycopyrronium or atropine. If bradycardia is refractory to antimuscarinic agents, intravenous isoprenaline or cardiac pacing may be indicated. Atropine or glycopyrronium may be given prophylactically in operations in which surgical stimulation increases the risk of bradycardia (e.g. ophthalmic surgery) or before a second dose of succinylcholine.

Tachycardia: During anaesthesia, tachycardia may be defined as a heart rate greater than 100 beat min−1. Tachycardia is a normal sign of increased sympathetic nervous system activity. It is observed in most patients at some time during the perioperative period. Sympathetic nervous system activity is increased by hypoxaemia, hypercapnia, inadequate anaesthesia, inadequate analgesia, hypovolaemia, hypotension and noxious stimulation such as airway manipulations or surgical incision. Other signs of sympathetic nervous activity may be present, including hypertension. Tachycardia is associated also with an increase in metabolic rate (e.g. fever, sepsis, burns, hyperthyroidism, malignant hyperthermia), or the administration of vagolytic drugs (e.g. atropine, pancuronium) or sympathomimetic drugs (e.g. ephedrine, adrenaline). Isoflurane and desflurane may also increase heart rate, particularly if introduced rapidly in a high concentration. Tachycardia reduces diastolic coronary perfusion and simultaneously increases myocardial work. This may precipitate myocardial ischaemia in patients with coronary artery or hypertensive heart disease.

Management. The cause of the tachycardia should be determined and treated, e.g. by providing additional analgesia, deepening anaesthesia or giving intravenous fluids for hypovolaemia. Sinus tachycardia may be associated with myocardial ischaemia despite exclusion or treatment of other causes. In this situation, the tachycardia may be controlled by careful intravenous titration of a β-blocker such as esmolol.

Arrhythmia: Arrhythmias are not infrequent during anaesthesia, and common causes are listed in Table 43.9. Extracellular potassium concentration has a profound effect on myocardial electrical activity. Hypokalaemia increases ventricular irritability and the risks of ventricular ectopics, tachycardia and fibrillation. This effect is potentiated in patients with ischaemic heart disease and in those receiving digoxin. Hyperventilation alters acid–base balance, with acute transmembrane redistribution of potassium. Serum potassium concentration decreases by approximately 1 mmol L−1 for every 2.5 kPa reduction in PaCO2. Life-threatening hyperkalaemia with atrioventricular conduction block or ventricular fibrillation may occur if succinylcholine is used in patients with burns or denervating injuries. Electrolyte disorders are discussed further in Chapter 12.

TABLE 43.9

Causes of Arrhythmias During Anaesthesia

Cardiorespiratory

Hypoxaemia

Hypotension

Hypocapnia

Hypercapnia

Myocardial ischaemia

Metabolic

Catecholamines:

Inadequate analgesia

Inadequate anaesthesia

Airway manipulation

Sympathomimetics

Hyperthyroidism

Electrolyte disturbance:

 Hypokalaemia/hyperkalaemia

 Hypercalcaemia/hypocalcaemia

Malignant hyperthermia

Surgical

Increased vagal tone (traction on eye, anus, peritoneum)

Direct cardiac stimulation (chest surgery, CVP cannulae)

Dental surgery

Drugs

Vagolytics (atropine, pancuronium)

Sympathomimetics (adrenaline, ephedrine)

Volatile anaesthetic agents (halothane, enflurane)

Digoxin

Management. Preoperative correction of fluid, electrolyte and acid–base imbalance is essential. Optimization of coronary artery disease and hypertension is also helpful in avoiding intraoperative arrhythmias (Ch 18).

Continuous intraoperative ECG monitoring is mandatory during anaesthesia because arrhythmias are so common. Lead II best demonstrates atrial activity and its use is recommended for routine ECG monitoring. As the ECG gives no indication of cardiac output or tissue perfusion, the detection of an abnormal cardiac rhythm should be followed by rapid assessment of the circulation. An absent pulse, severe hypotension or ventricular tachycardia or fibrillation should be treated as a cardiac arrest. The anaesthetist must exclude hypoxaemia, hypotension, inadequate analgesia and light anaesthesia as possible causes of arrhythmia. Correction of the precipitating factor is often the only treatment required. If the arrhythmia persists and causes a significant decrease in cardiac output, if it is associated with myocardial ischaemia or if it predisposes to ventricular tachycardia or fibrillation, intervention with a specific antiarrhythmic agent or electrical cardioversion is indicated. Serum potassium concentration should be measured if ventricular arrhythmias occur, especially if the patient is receiving digoxin.

Atrial Arrhythmias: These may reduce the atrial contribution to left ventricular filling, resulting in a decrease in cardiac output. Premature atrial contractions and wandering atrial pacemakers are common and of little consequence.

Junctional rhythm is associated usually with the use of halothane. Reduction in concentration or change of volatile agent is indicated. Administration of an anticholinergic drug may be required to restore sinus rhythm.

Accelerated nodal rhythm may be precipitated by an increase in sympathetic tone in the presence of a sensitizing volatile anaesthetic agent. Adjusting the depth of anaesthesia or changing the anaesthetic agent is appropriate treatment.

Supraventricular tachycardia (SVT) may occur at any time during the perioperative period in susceptible patients, such as those with Wolff–Parkinson–White or other ‘pre-excitation’ syndromes. If attempts to increase vagal tone and terminate the SVT by carotid sinus or eyeball massage are unsuccessful, the treatment of choice is adenosine by rapid intravenous injection. This is safe and effective during haemodynamic instability because its duration of action is less than 60 s. It blocks atrioventricular conduction without compromising ventricular function. Adenosine should not be given to patients with asthma or atrioventricular conduction block. If adenosine is unavailable and the patient is normotensive, intravenous verapamil or esmolol may be given in increments. Verapamil may cause prolonged hypotension and depression of ventricular function, especially in the presence of anaesthetic agents which cause myocardial depression; β-blockers should not be used in conjunction with verapamil because of their unpredictable synergy, which may result in profound bradycardia. DC cardioversion is indicated if the SVT is associated with hypotension and adenosine is unavailable.

Atrial flutter or fibrillation may be observed during anaesthesia de novo or as a paroxysmal increase in ventricular rate in patients with pre-existing atrial flutter or fibrillation. After correcting any precipitating factors, rate control with a beta-blocker is the usual first choice. Digoxin may be appropriate for patients with heart failure. Amiodarone may also be used. Immediate cardioversion should be considered if the ventricular rate is fast with a significant reduction in cardiac output.

Ventricular Arrhythmias: Premature ventricular contractions (PVCs) are common in healthy patients and may be present preoperatively. If associated with a slow atrial rate (escape beats), increasing the sinus rate by administration of an anticholinergic drug should abolish them. In other situations, an underlying cause should be sought before antiarrhythmic agents are considered, as PVCs rarely progress to more serious arrhythmias unless they are multifocal and frequent or if there is underlying myocardial ischaemia or hypoxaemia. Halothane lowers the threshold for catecholamine-induced ventricular arrhythmias, and this effect is exacerbated by hypercapnia. Halothane should be used with care in patients receiving sympathomimetic drugs (including local anaesthetics containing adrenaline) and in patients taking aminophylline or drugs that block noradrenaline re-uptake, such as tricyclic or other antidepressants. The maximum recommended dose of adrenaline for infiltration in the presence of halothane is 100 μg (10 mL of 1 in 100 000) during any 10-min period, although the rate of absorption depends on the site of injection. The use of isoflurane carries a much lower risk of development of arrhythmias and sevoflurane has an even lower potential to cause myocardial sensitization to catecholamines.

Heart block. Impulses from the atria may be variably conducted to the ventricles. Degrees of impairment range from a small time delay in onward transmission to complete failure of onward propagation of impulses. Heart block may result in bradycardia and reduced cardiac output. Treatment is seldom necessary during anaesthesia, but minor degrees of atrioventricular block may progress to complete heart block, in which atrial impulses do not reach the ventricles. In this situation, bradycardia is usually severe and the atria no longer assist in filling the ventricles before ventricular systole. Cardiac output may fall to life-threateningly low levels, and immediate treatment is necessary. This includes intravenous isoprenaline and transcutaneous or transvenous cardiac pacing.

Ventricular tachycardia is uncommon during anaesthesia. If it is not causing significant hypotension, current ALS guidelines recommend amiodarone 300 mg i.v. over 20-60 min followed by 900 mg over 24 hr. DC cardioversion may be required if the patient is unstable. Ventricular tachycardia with no cardiac output should be treated according to ALS guidelines for cardiac arrest.

Ventricular fibrillation is very uncommon in association with anaesthesia. It requires immediate DC cardioversion.

Any arrhythmia which causes the loss of a palpable pulse should be treated as for cardiac arrest, with immediate external (or internal, if appropriate) cardiac massage, ventilation of the lungs with 100% oxygen and drug treatment as specified in the appropriate Advanced Life Support protocol (see Ch 47).

Myocardial Ischaemia

The heart has the highest oxygen consumption per tissue mass of almost all the organs (second only to the carotid body). Resting coronary blood flow is 250 mL min−1 and represents 5% of the cardiac output. The oxygen extraction ratio of the myocardium is 70–80%, compared with an average of 25% for other tissues. Increased oxygen consumption must be matched by an increase in coronary blood flow. Ischaemia results when the oxygen demand outstrips supply. Even very brief reductions in supply result in ischaemia, which may lead rapidly to infarction and permanent loss of muscle function in the affected area.

Myocardial oxygen delivery is the product of arterial oxygen content and coronary artery blood flow. The diastolic pressure time index (DPTI) reflects coronary blood supply. It is the product of the coronary perfusion pressure (predominantly diastolic arterial pressure) and diastolic time. Oxygen demand is represented by the tension time index (TTI), the product of systolic pressure and systolic time.

The ratio of DPTI/TTI is the endocardial viability ratio (EVR) and represents the myocardial oxygen supply–demand balance. The EVR is usually greater than one. A value of less than 0.7 is associated with subendocardial ischaemia. Such a value may be reached in a patient with the data shown in Table 43.10.

It is clear from the above that tachycardia is particularly dangerous in generating myocardial ischaemia, while systolic hypertension and diastolic hypotension may also contribute. Patients with coronary artery disease are most at risk. Intraoperative myocardial ischaemia may manifest clinically as arrhythmia, hypotension or pulmonary oedema. It is diagnosed by ECG ST-segment changes (usually depression), although these are not always detected reliably without computer-assisted analysis. The use of the V5 electrode is recommended for ECG monitoring in susceptible patients (e.g. the CM5 configuration; see Ch 16) because it is the most sensitive ECG lead for the detection of left ventricular ischaemia. When used alone, it may detect up to 85% of the ST abnormalities on a standard 12-lead ECG.

Transoesophageal echocardiography may detect abnormal myocardial wall motion, which is a sensitive indicator of ischaemia and is associated with increased perioperative morbidity. Regional wall dysfunction often persists into the postoperative period without clinical signs. Increased myocardial work during this period (e.g. from pain) may precipitate further ischaemia or infarction in susceptible patients. While the risk of infarction in the general surgical population is low, the overall mortality rate following perioperative myocardial infarction approaches 50%.

Management: Preoperative preparation of the at-risk patient includes optimization of anti-anginal and antihypertensive medication, suppression of anxiety and assurance of normal intravascular volume. During anaesthesia, the risks associated with ischaemia are minimized by the use of an appropriate anaesthetic technique and early detection by the use of appropriate monitoring in susceptible patients.

If ischaemia is detected, arterial oxygen content should be increased by optimizing PaO2 and haemoglobin concentration. Tachycardia should be controlled by ensuring that analgesia, anaesthesia and intravascular volume are satisfactory. If systolic hypertension, diastolic hypotension or tachycardia exist, then these may be controlled pharmacologically; most commonly, increments of a vasodilator or β-blocker are administered to treat hypertension or tachycardia. If signs of myocardial ischaemia persist, the use of a venodilator such as glyceryl trinitrate by intravenous infusion should be considered.

Embolus

An embolus is the passage of a non-blood mass through the vascular system. Venous emboli usually become lodged in the lung, where they impair gas exchange and cause a local inflammatory reaction. Arterial emboli cause obstruction, which may result in distal ischaemia.

Thromboembolus

Embolization of thrombus occurs usually from the deep veins of the legs or pelvis. It is uncommon during anaesthesia. It is often preceded by a period of immobilization, so that patients whose hospital stay is extended or who have suffered major trauma are at highest risk. Other risk factors include malignancy, smoking, pelvic and limb surgery, the oral contraceptive or hormone replacement therapy, and a past history of venous thromboembolism. Venous stasis caused by venous compression, hypovolaemia, hypotension, hypothermia or the use of tourniquets also increases the risk of deep venous thrombosis. Veins may sustain trauma during positioning and surgery, and increased blood coagulability, with a consequent increase in the risk of venous thrombosis, is a consequence of the stress response to surgery.

During anaesthesia, pulmonary thromboembolism may present with tachycardia, hypoxaemia, arrhythmia, hypotension, bronchospasm, an acute decrease in the end-tidal carbon dioxide concentration or cardiovascular collapse.

Management: Patients with risks factors should be managed actively to prevent deep venous thrombosis. The oral contraceptive pill or hormone replacement therapy should be stopped at least 6 weeks before elective surgery in patients at risk. Prophylactic heparin, graduated compression stockings and intraoperative intermittent calf compression reduce the likelihood of new thrombosis. The use of subarachnoid or epidural anaesthesia reduces the risk of postoperative venous thromboembolism in some surgical groups.

If intraoperative pulmonary embolism is suspected, the lungs should be ventilated with 100% oxygen and bronchodilator therapy, fluid loading and inotropic support of the circulation should be considered. In extreme presentations, cardiac arrest protocols should be used. After management of the initial haemodynamic disturbance, thrombolytic therapy (if not contraindicated), anticoagulation and, rarely, surgical removal of the embolus may be indicated.

Gas Embolus

Gas usually enters the circulation through a surgical wound. A subatmospheric venous pressure greatly encourages the entrainment of air into the venous system. Therefore, positions that place the operative site above the right atrium carry an increased risk of air embolism. Such positions include sitting, park bench, knee-chest and head-up. Vascular catheters are another potential route for air entry, particularly during their insertion. Gas embolism (usually carbon dioxide) may also occur during laparoscopy and thoracoscopy.

Clinical presentation varies with the volume and rate of gas entry into the circulation. An entry rate of 0.5 mL kg−1 min−1 has been reported to produce clinical signs. If a significant volume of gas enters the right side of the heart, an airlock may develop, preventing ejection of blood and effectively halting cardiac output. A ‘millwheel murmur’ may be heard via a precordial or oesophageal stethoscope, although this is reported to be a late sign and only occurs with very large emboli. The sudden decrease in right ventricular output results in a rapid decrease in end-tidal carbon dioxide concentration. Hypoxaemia, tachycardia, ECG changes (especially arrhythmia) and an increase in pulmonary artery pressure follow.

Transoesophageal echocardiography and precordial Doppler ultrasound are the most sensitive monitors for gas embolus. Clinical and ECG signs have a low sensitivity for detection of gas embolism. As the foramen ovale is potentially patent in more than 25% of the population, an increase in right heart pressure may open the foramen in these patients. Paradoxical gas embolism via this route or across the pulmonary capillary bed to the coronary or cerebral circulations may cause myocardial or cerebral ischaemia and infarction.

Management: Prevention of intraoperative air embolus requires adjustment of the patient’s position and the site of the operative field with respect to the right atrium. If air embolism is detected, further air entry is prevented by flooding the operative site with saline. During head and neck procedures, the venous pressure at the surgical site may be increased by compressing the jugular veins. If possible, the operative site should be lowered relative to the right atrium. The application of PEEP increases venous pressure and reduces further ingress of air.

During insufflation procedures, the surgeon should be instructed to depressurize the insufflated body cavity. If the gas embolus is symptomatic, administration of nitrous oxide should be discontinued to avoid expansion of gas bubbles and the lungs should be ventilated with 100% oxygen. Carbon dioxide is absorbed by tissues much more rapidly than air. Carbon dioxide embolism usually results in transient hypotension or cardiac arrest, whereas air embolism is often fatal.

Occasionally, gas may be aspirated from the right ventricle or atrium via a venous catheter. However, insertion of a catheter is usually impractical and time-consuming, and aspiration is only worth attempting if a catheter is already in place. Expansion of the intravascular fluid volume, inotropic support of the circulation and internal or external cardiac massage may be necessary. Placing the patient in a head-down left lateral position may help by allowing gas from the right ventricle to escape into the atrium and vena cava.

Other Emboli

Fat dislodged from long bone fractures may embolize to the lungs. Patients typically develop sudden mental disturbance, shortness of breath, hypoxaemia, and axillary and subconjunctival petechiae. Onset is usually 2–48 h after the injury. Fat globules may be seen in the urine and sputum, or in the retinal vessels during fundoscopy. There should be a high index of suspicion if unexpected haemodynamic events or hypoxaemia occur in patients undergoing surgery for pelvic or lower limb fractures. Treatment is with intravenous fluids, steroids and ventilatory support as necessary. The use of intravenous albumin to bind free fat is controversial.

Other material which may embolize includes tumour fragments, amniotic fluid and orthopaedic cement. Air or clot may embolize via arterial cannulae and produce distal ischaemia.

Neurological Complications

Awareness

Recall of intraoperative events occurs in 0.03–0.3% of anaesthetics. Such recall may be spontaneous, or may be provoked by postoperative events or questioning. Awareness during anaesthesia may be a very distressing event for a patient, particularly if it is accompanied by awareness of the painful nature of an operation or the presence of paralysis. However, the majority of recalled events are not painful, and 80–90% of patients recalling intraoperative events have not experienced pain. Awareness may have psychological sequelae including insomnia, depression and post-traumatic stress disorder (PTSD) with distressing flashbacks.

The risk of awareness correlates with depth of anaesthesia. Light anaesthesia, particularly when the patient is paralysed by muscle relaxants, is associated with the highest risk of awareness. Awareness is associated frequently with poor anaesthetic technique. Errors include the omission or late commencement of volatile agent, inadequate dosing or failure to recognize the signs of awareness. Underdosing of anaesthetic agent may occur during hypotensive episodes, when anaesthetic is withheld in an attempt to maintain arterial pressure. Breathing system malfunctions, misconnections and disconnections have been associated with awareness.

The signs of awareness in a paralysed patient arise from activation of the sympathetic nervous system (sweating, tachycardia, hypertension, tear formation), and dilatation and reactivity to light of the pupils. Unparalysed patients experiencing noxious stimulation may move or grimace. Depth of anaesthesia may be assessed through clinical examination, monitoring of the patient’s expired volatile agent concentration or using specialized monitoring equipment. Such equipment includes processed electroencephalography such as the bispectral index and auditory evoked potential monitoring systems. If the end-tidal concentrations of inhaled anaesthetic agents summate to a total of greater than about 0.8–0.9 MAC, it is exceptionally unlikely that a patient experiences intraoperative awareness.

Awareness is more likely to occur during emergency and obstetric surgery, during neuromuscular paralysis, during periods of hypotension and in patients treated with a β-blocker (which prevents tachycardia and hypertension). The use of intravenous drugs for maintenance of anaesthesia (e.g. propofol target-controlled infusion) may be associated with an increased risk of awareness compared with the use of inhaled anaesthetic agents. It is not possible currently to monitor, in real time, the concentration of intravenous agents in blood, while it is possible to monitor exhaled volatile agents. Additionally, the scatter about the mean of the minimum inhibitory concentration (MIC) for intravenous agents is greater than the equivalent for inhaled agents (MAC).

Management: If the anaesthetist suspects, intraoperatively, that a patient may be experiencing awareness, anaesthesia should be deepened immediately. If the arterial pressure is low despite an inadequate dose of anaesthetic agent, then the arterial pressure should be supported through the use of intravenous fluids, modification of ventilatory pattern or intravenous administration of a vasopressor, and anaesthesia deepened appropriately. Consideration should be given to the use of an intravenous benzodiazepine (e.g. midazolam 5 mg). Some retrograde amnesia may be gained and further recall is made less likely through the anterograde amnesic effect.

If a patient complains in the postoperative period of intraoperative awareness, the anaesthetist should be informed and should visit the patient. The anaesthetist should establish the timing of the episode and try to distinguish between dreaming and awareness. If there is genuine awareness and a clear anaesthetic error, then a prompt apology and explanation should be provided. All details should be recorded in the case notes. The situation may be exacerbated if staff refuse to believe the patient. It is essential to offer follow-up counselling for the patient and to inform the patient’s general practitioner. See the Medicolegal aspects of complications section above for further detail of dealing with any subsequent formal complaints.

Awareness occasionally occurs despite apparently excellent practice and in the absence of equipment malfunction. Successful defence against litigation requires that the anaesthetist has made thorough records. It is advisable that the anaesthetist always records the timing (absolute and relative to surgery) and dose of anaesthetic agents (inhaled or intravenous).

Neurological Injury

Ischaemia of the Central Nervous System

Transient disruptions of central nervous system (CNS) perfusion and oxygenation are common during anaesthesia. However, prolonged reduction in oxygenation of the CNS may result in ischaemia or infarction. Ischaemic injury varies from minimal, focal dysfunction to stroke or death. The mechanism is related usually to hypoxaemia and/or hypotension. The risk of ischaemic brain damage related to hypotension is increased in patients with atherosclerosis, and, in particular, cerebrovascular disease. A history of previous transient ischaemic attacks or stroke makes CNS injury much more likely during anaesthesia. Rarely, intracerebral haemorrhage may occur during anaesthesia, with consequent local compression and downstream ischaemic injury. Although the risk is increased if arterial pressure has been very high, there have been reports of intracerebral haemorrhage during anaesthesia without episodes of hypertension. It is likely that previously undetected vascular abnormalities were present in these cases.

The cervical spinal cord may be damaged during tracheal intubation and positioning in patients with cervical spine instability from fractures, rheumatoid arthritis or congenital conditions such as Down’s syndrome. Extreme rotation, flexion or extension of the neck may cause cerebral ischaemia because of vertebrobasilar insufficiency in susceptible patients. Ischaemic spinal cord injury may also occur during major vascular and spinal surgery, when the local arterial supply may be compromised.

Temperature

Hypothermia

Body temperature very commonly decreases during anaesthesia. A decrease to a core temperature below 36 °C represents hypothermia. Hypothermia causes physiological derangement and increases perioperative morbidity (see also Ch 11).

Heat production is decreased during anaesthesia. Anaesthetic agents alter hypothalamic function, reduce metabolic rate, abolish behavioural responses to heat loss and abolish shivering. Heat loss increases during anaesthesia and surgery because of heat redistribution to the peripheries by vasodilatation and increased radiation by the exposure of large, moist surfaces. Evaporative heat loss is increased by ventilation of the lungs with cold dry gas, the use of wet packs and operations on open body cavities. Heat loss is exacerbated by low ambient temperature, and high air flow in the operating theatre promotes convective and evaporative loss. Irrigation and intravenous infusion of cold fluids are also associated with increased heat loss. The risks of hypothermia are greatest in neonates and infants, patients with a low metabolic rate (such as the elderly) and patients with burns.

The effects of hypothermia are dependent upon the change in core temperature. Metabolic rate reduces by approximately 10% for each 1 °C reduction in core temperature. Cardiac output decreases and the affinity of haemoglobin for oxygen is increased, causing a reduction in tissue oxygenation. Significant hypothermia is associated with metabolic (lactic) acidosis, oliguria, altered platelet and clotting function, and reduced hepatic blood flow with slower drug metabolism. The MAC of volatile agents is reduced (also by approximately 10% for each 1 °C decrease) and muscle relaxants have a longer and more variable duration of effect. Postoperative shivering increases oxygen consumption and myocardial work. Peripheral vasoconstriction increases afterload, further increasing the risk of myocardial ischaemia. Hypothermia also increases the risk of postoperative infections because of suppression of function of the immune system.

Management: Ambient temperature and humidity should be maintained as high as is comfortable for staff working in the operating theatre. The patient should be protected from the cool ambient environment during all phases of anaesthesia and during transfers. A convective warming blanket (e.g. Bair Hugger™), which surrounds the patient with a microenvironment of warm air, is particularly effective. The head and any exposed moist viscera lose heat particularly quickly and wrapping these is effective in preventing radiation and evaporative heat loss. Cold intravenous fluids should be warmed where possible, although this should not compromise the administration of adequate volumes. Inspired gases should be warmed and humidified. A heat and moisture exchanging device is very effective in this regard, and is often combined with a microbial filter.

In all but very short operations, the measures described above should be started as soon as possible after induction of anaesthesia, and core temperature should be monitored both to detect hypothermia and to adjust the warming devices to prevent hyperthermia developing. If core temperature remains significantly below 35 °C at the end of surgery, consideration should be given to keeping the patient anaesthetized until temperature is normalized. This applies particularly to patients with cardiovascular or cerebrovascular disease, or metabolic abnormalities.

Induced deep hypothermia (as low as 16 °C) may be used for neurosurgical, aortic or cardiac procedures in which circulatory arrest is required to provide the necessary operating conditions. Large reductions in the metabolic rate reduce tissue oxygen consumption and allow a short period of circulatory arrest. Hypothermia reduces cerebral oxygen consumption and is used in the management of severe head injury or after cerebral hypoxic/ischaemic events.

Hyperthermia

Hyperthermia during anaesthesia may be defined as a core body temperature greater than 37.5 °C and is usually caused by an increase in heat production. Common causes include sepsis and infection, drug reactions (anaphylaxis, incompatible blood transfusion), excessive catecholamine activity (phaeochromocytoma, thyroid storm) and malignant hyperthermia. Elevated metabolic rate may lead to acidosis. Without treatment, sweating and vasodilatation produce hypovolaemia and tissue hypoxia. Seizures and CNS damage may ensue.

Malignant Hyperthermia

Malignant hyperthermia (MH) is an inherited disorder of muscle. The incidence varies geographically from 0.02% to 0.002% (1 in 5000 to 1 in 50 000). MH had a mortality rate of 75% at the time it was identified in 1960. Treatment consisted of cooling the patient and treating complications as they arose. The cause was then unknown, and could not be treated. Currently, mortality is approximately 5%. Increased awareness amongst anaesthetists has resulted in earlier diagnosis and treatment. Since 1979, dantrolene has been available for the treatment of MH and has resulted in the dramatic decline in death and disability from the condition.

Malignant hyperthermia is an inherited disorder. Mutations in the human ryanodine receptor in skeletal muscle (a calcium-release channel with a role in excitation-contraction coupling) are apparent in some families. Predisposition to MH has been identified in only three rare clinical myopathies. Abnormal calcium release and re-uptake by the sarcoplasmic reticulum lead to myofibrillar contraction, depletion of high-energy muscle phosphate stores, accelerated metabolic rate, increased carbon dioxide and heat production, increased oxygen consumption and metabolic acidosis. The usual triggering agents are succinylcholine or any volatile anaesthetic agent.

The MH syndrome may present at any time during the perioperative period. The clinical features and their severity vary considerably. The most consistent and early signs are unexplained tachycardia and an increase in the end-tidal PCO2. Spontaneously breathing patients may present with tachypnoea. MH should be considered in any anaesthetized patient if core temperature increases during anaesthesia. Core temperature increases typically by 2 °C h−1 and may exceed 40 °C. Muscle rigidity is common and usually involves the limbs and jaw. Without treatment, the full MH syndrome may develop, with sweating, cyanosis, mottled skin, hypoxaemia, ventricular arrhythmias and severe metabolic and respiratory acidosis. Muscle injury causes significant potassium release, with ECG signs of hyperkalaemia. Coagulopathy hypocalcaemia, oliguria, myoglobinuria and acute renal failure are other sequelae.

Masseter muscle rigidity (MMR) occasionally complicates anaesthesia, particularly following administration of succinylcholine. This progresses to MH in approximately 10% of cases.

Management: Administration of a volatile anaesthetic agent should be discontinued immediately and the lungs hyperventilated with 100% oxygen. The anaesthetic breathing system should be replaced with an unused (and therefore uncontaminated) system. Anaesthesia should be maintained with an intravenous agent. The trachea should be intubated at the earliest opportunity if a tracheal tube is not already in place. Experienced help should be obtained in both the operating theatre and the laboratory, and the operation must be abandoned as soon as possible. Specific tasks should be allocated (e.g. preparation of dantrolene, monitoring, managing communication with lab etc.). Intravenous dantrolene should be given as an immediate bolus (2.5 mg/kg). Further boluses of 1 mg/kg should be given as required to a maximum of 10 mg/kg until the increase in PECO2 is controlled. Dantrolene is packaged as a powder which takes several minutes to reconstitute. For a 70 kg adult, the intial dose would be 9 vials of dantrolene (20 mg each), mixed with 60 mL sterile water. It is a skeletal muscle relaxant and causes muscle weakness in large doses. The massive increase in metabolic rate commonly produces severe acidosis, and large amounts of intravenous fluids and sodium bicarbonate may be required. Ice packs should be placed around the neck, axillae and groin, and chilled saline should be infused intravenously. If necessary, gastric, rectal and peritoneal lavage with iced saline may be life-saving if hyperthermia is severe. Cardiopulmonary bypass has been used in severe cases.

Core temperature, CVP, direct arterial pressure and urine output should be monitored. Acid–base status, arterial gas tensions, coagulation status and serum electrolyte concentrations should be measured frequently. Hyperkalaemia is common, and should be treated with intravenous glucose and insulin. Arrhythmias usually resolve after treatment of hyperkalaemia and acidosis, but specific antiarrhythmic drugs may be required. Calcium channel blockers should be avoided due to their interaction with dantrolene. Renal hypoperfusion and medullary hypoxia may result rapidly in acute tubular necrosis. Urine output should be maintained by ensuring an adequate circulating blood volume and using intravenous mannitol. Haemofiltration may be required to correct severe biochemical abnormalities or renal dysfunction. The syndrome often persists beyond the initial acute episode, and hyperthermia may return up to 48 h later. The patient should be managed in a high-dependency area and oral dantrolene should be continued during this time.

Following an episode of MH, the patient should be referred to a specialist centre for further assessment. The tests used to identify individuals with MH susceptibility vary among centres. The most common test is halothane- and caffeine-induced contracture of a muscle specimen. Less invasive genetic tests are being developed. First-degree family members should also be screened for MH.

Equipment Malfunction

About a third of all critical incidents are related to equipment failure and most are preventable. Most equipment problems have implications for the patient and some have been described above (e.g. leaks and disconnections involving the anaesthetic machine and gas delivery system). Meticulous preparation of equipment prevents most malfunctions, while a systematic approach to identifying problems as they arise should prevent most potentially serious complications.

Monitoring equipment may provide inaccurate and misleading data. Non-invasive arterial pressure devices and pulse oximeters often produce inaccurate readings. Movement, diathermy and poor contact with the patient may contribute to artefact in monitored values. Incorrect data may lead to incorrect treatment of the patient, and artefact must always be borne in mind as a cause for a sudden change to a value outside the acceptable range. Data supplied by monitors must always be used in conjunction with clinical examination of the patient and should be considered in context (e.g. type of surgery, patient’s pre-existing illnesses).

Drug Reactions

Hypersensitivity

Susceptible patients may display an enhanced immunological reaction to a trigger, which may be a drug or an environmental agent. These hypersensitivity reactions may be anaphylactic or anaphylactoid. Some drugs produce histamine release directly, without an immunological basis.

The incidence of anaphylaxis varies according to the antigen involved. Of the intravenous drugs, reactions are most commonly to muscle relaxants (1 in 5000 to 1 in 10 000). Succinylcholine is the most immunogenic, although reactions to all non-depolarizing relaxants have also been reported. The majority of reactions are IgE-mediated. There is significant cross-reactivity between muscle relaxants and other drugs which contain a quaternary ammonium group. Pancuronium appears to be the least likely muscle relaxant to cause anaphylaxis.

Reactions to intravenous induction agents are far less common (1 in 15 000 to 1 in 50 000). Hypersensitivity to benzodiazepines and etomidate is rare and these drugs do not cause direct histamine release.

Hypersensitivity to local anaesthetics is very rare. Reactions are more likely to be the result of dose-related toxicity, sensitivity to the effects of added vasoconstrictor or a reaction to preservatives such as paraben, sulphites and benzoates. Amide local anaesthetic agents are less allergenic than esters.

Antibiotics are frequently implicated in allergic reactions. Penicillins are most often to blame, and there is cross-reactivity with cephalosporin antibiotics in 10% of penicillin-allergic patients.

Latex is emerging as one of the more important causes of anaphylaxis during anaesthesia and surgery. Reactions usually begin 30–60 min following exposure, and may be very severe. Previous frequent exposure to latex (e.g. spina bifida) is a strong risk factor for latex allergy. There is often a history of intolerance to some foods, including banana and avocado. Many medical devices contain latex (e.g. arterial pressure cuffs, surgical gloves), and it is important that all such products are eliminated from the care of latex-susceptible patients.

Anaphylaxis also occurs in response to radiocontrast media, blood products, colloid solutions, protamine, streptokinase, aprotinin, atropine, bone cement and opioids. Allergic reactions to volatile agents are exceptionally uncommon.

Anaphylaxis (type 1 hypersensitivity) is an IgE-mediated reaction to an antigen. Antibodies bind to mast cells, which degranulate, releasing the chemical mediators of anaphylaxis. These include histamine, prostaglandins, platelet-activating factor (PAF) and leukotrienes. The signs produced by the actions of these mediators of anaphylaxis include urticaria, cutaneous flushing, bronchospasm, hypotension, arrhythmia and cardiac arrest. Only one of these signs may be present, and it is important to have a high index of suspicion. Anaphylaxis has been reported in patients without apparent previous exposure to the specific antigen, probably because of immunological cross-reactivity. This is true particularly of reactions to muscle relaxants; cosmetics and some foods contain structurally similar compounds.

Anaphylactoid reactions are not IgE-mediated, although the clinical presentation is identical to anaphylaxis. The precise immunological mechanism is not always evident, although many reactions involve complement, kinin and coagulation pathway activation.

Non-immunological histamine release is caused by the direct action of a drug on mast cells. The clinical response depends on both the drug dose and the rate of delivery but is usually benign and confined to the skin. Anaesthetic drugs which release histamine directly include d-tubocurarine, atracurium, doxacurium, mivacurium (all of similar chemical derivation), morphine and pethidine. Clinical evidence of histamine release, usually cutaneous, occurs in up to 30% of patients during anaesthesia. However, some very serious reactions have been reported in association with administration of atracurium and mivacurium.

Hypersensitivity reaction should be considered in the differential diagnosis of any major cardiorespiratory problem during anaesthesia. Reactions are more common in women, and in patients with a history of allergy, atopy or previous exposure to anaesthetic agents. Over 90% of reactions occur immediately after induction of anaesthesia. There is a clinical spectrum of severity from the mildest urticaria to immediate cardiac arrest. Coughing, skin erythema, difficulty with ventilation and loss of a palpable pulse are common early signs. Reactions often involve a single, major physiological system (e.g. bradycardia and profound hypotension without bronchospasm). This may make diagnosis confusing, but every instance of bronchospasm, unexpected hypotension, arrhythmia or urticaria should be considered to be due to anaphylaxis until proved otherwise. Erythema of the skin may be short-lived or absent because cyanosis from poor tissue perfusion and hypoxaemia may occur rapidly and be profound. The conscious patient may experience a sense of impending doom, dyspnoea, dizziness, palpitations and nausea. The differential diagnosis includes anaesthetic drug overdose and other causes of bronchospasm, hypotension or hypoxaemia.

Management: Death may result from tissue hypoxia secondary to inadequate perfusion and/or hypoxaemia. Early recognition and treatment are essential. The aims of management are to obtund the effect of the anaphylaxis mediators and to prevent their further release. A management ‘drill’ should be used (Table 43.11). The early use of adrenaline is life-saving during severe anaphylactic reactions because it treats the symptoms (through peripheral vasoconstriction, increased cardiac output and bronchodilation) and the cause (through mast cell restabilization). Corticosteroids and histamine H1-receptor antagonists have a delayed onset of action, but have a role in later management.

TABLE 43.11

Drill for the Management of Major Anaphylaxis

Initial Therapy

Stop administration of drug(s) likely to have caused the anaphylaxis
Call for help and note the time

Maintain airway. Give 100% oxygen

Lay patient supine with feet elevated

Give adrenaline. This may be given intramuscularly in a dose of 0.5 (0.5 of 1:1000) and may be repeated after 5 min according to the arterial pressure and pulse until improvement occurs. Alternatively, adrenaline may be administered intravenously. The dose given depends upon the severity of the reaction. Minor symptoms may be treated with 50 μg boluses, while cardiovascular collapse requires a bolus dose of 1000 μg. Further doses are likely to be required

Start intravascular volume expansion with crystalloid or colloid

Secondary Therapy

Antihistamines (chlorpheniramine 10 mg i.v.)

Corticosteroids (hydrocortisone 200 mg i.v.)

Catecholamine infusions (starting doses:

adrenaline 0.05–0.1 μg kg−1 min−1 noradrenaline 0.05–0.1 μg kg−1 min−1)

Consider bicarbonate (0.5 mmol kg−1 i.v.) for acidosis, repeated as necessary

Airway evaluation (before extubation)

Bronchodilators (salbutamol 2.5 mg kg−1) may be required for persistent bronchospasm

Anaphylaxis may persist, despite a promising initial response to management. Therefore, subsequent management should be in a critical care area (e.g. an intensive care unit). An infusion of adrenaline may be required to treat persistent hypotension or bronchospasm, and in the interests of preventing further mast cell degranulation. Progressive oedema involving the airway may develop rapidly and tracheal intubation and mechanical ventilation of the lungs are recommended until the patient is clinically stable and airway patency guaranteed after a period of observation. Blood coagulation status, serum electrolyte concentrations and arterial gas tensions should also be measured regularly.

Venous blood samples (5–10 mL clotted blood) should be obtained as early in the reaction as possible, but resuscitation should not be delayed to take this sample. The most important sample is 1 h after the beginning of the reaction. A third sample at 24 hours or at the allergy clinic should be taken for ‘baseline’ tryptase levels. The samples should be separated and stored at −20 °C for subsequent measurement of serum tryptase concentration. Serum tryptase is a specific marker of mast cell degranulation, and has replaced the measurement of serum IgE as the test of choice for confirming a diagnosis of anaphylaxis. If death occurs, the serum tryptase concentration can be measured in blood taken at post mortem examination. This can be very helpful in identifying the cause of death. However, a negative test does not exclude a hypersensitivity reaction.

The patient should be reviewed at a later date by an appropriate clinician (e.g. a clinical immunologist) and further investigations performed. Skin prick tests are recommended to identify the culpable agent and any associated cross-reactivity. Such cross-reactivity is commonly found when the reaction has been to muscle relaxants, and the patient is frequently allergic to several related compounds. If allergy is confirmed, then a MedicAlert® bracelet should be worn by the patient. The details of the reaction must be recorded in the medical records and reported to the patient’s general practitioner and the appropriate adverse drug reactions body (AAGBI National Anaesthetic Anaphylaxis Database in the UK).

Other Drug Reactions

An idiosyncratic drug reaction is a qualitatively abnormal and harmful drug effect which occurs in a small number of individuals and is precipitated usually by small drug doses. There is often an associated genetic defect and the reaction may be severe or even fatal.

Succinylcholine sensitivity, malignant hyperthermia (see above) and acute intermittent porphyria are important examples of drug idiosyncrasy in anaesthetic practice.

Regional Anaesthesia

Central Techniques

Epidural and subarachnoid anaesthesia are often chosen to reduce the patient’s perioperative risk. However, these techniques may pose independent risks.

Infection and Haematoma: Spinal abscess presents as sudden, painless loss of motor function, usually several days after performance of the block, and is a devastating complication of central nervous blockade. Meticulous aseptic technique helps to reduce the incidence of this complication but some cases arise spontaneously, probably as a result of bacteraemia caused by surgery and inoculation of a small and otherwise asymptomatic epidural haematoma. Urgent magnetic resonance imaging and referral to a neurosurgeon are indicated if spinal abscess is suspected.

Epidural haematoma is a common complication of epidural catheter placement. The large majority of haematomata are asymptomatic and resolve spontaneously. They may be apparent only upon spinal imaging. Large haematomata may cause permanent nerve injury. Epidural catheters should not be inserted in patients who are receiving warfarin or intravenous heparin, or who have abnormal coagulation for some other reason. Caution should be exercised if a patient is receiving low-dose heparin for thromboprophylaxis. At least 12 h should be allowed to elapse between administration of low-molecular-weight heparin prophylaxis and epidural block. If blood is obtained via the needle or catheter during insertion and the patient is expected to be fully heparinized (e.g. during cardiac or major vascular surgery), the procedure should be postponed for 24 h. As with spinal abscesses, urgent imaging and referral to a neurosurgeon are indicated. Often, imaging is delayed because numbness and weakness are attributed to the effects of the epidural block; low concentrations of local anaesthetic (e.g. 0.1% or 0.125% bupivacaine) do not cause weakness and cause minimal numbness, and there should be a high level of suspicion about the possibility of epidural haematoma if these signs arise in the postoperative period.

Local Anaesthetic Toxicity

Local anaesthetic drugs may cause toxic side-effects when excessive serum concentrations are achieved. This is most commonly caused by accidental intravenous injection, excessively rapid absorption or absolute overdosage. Some sites of injection display a much more rapid uptake into the systemic circulation, usually because of local vascularity. Intercostal nerve blocks result in higher serum concentrations than subcutaneous infiltration, which produces higher serum concentrations than plexus blocks.

Cerebral symptoms occur first. Dizziness, drowsiness, confusion, tinnitus, circumoral tingling, anxiety and a metallic taste are common signs of toxicity. Patients should be asked about the presence of these symptoms. In severe toxicity, tonic-clonic convulsions occur. Cardiovascular symptoms include bradycardia with hypotension, although solutions which contain adrenaline may produce tachycardia and hypertension. Cardiovascular collapse occurs usually at 4–6 times the serum concentration at which convulsions occur. Local anaesthetics directly depress the myocardium and cause systemic vasodilatation. Cardiovascular collapse occurs earlier with bupivacaine than with lidocaine because of myocardial binding. Severe and intractable arrhythmias may occur with accidental intravenous injection. The toxicity of local anaesthetics is increased by a rapid rate of increase of serum concentration. Thus, a rapid intravenous injection of a small dose has the potential to cause toxicity.

Management: Intravenous access should be secured and adequate resuscitation equipment and drugs should be immediately available before a local anaesthetic block is undertaken. The patient should be adequately monitored. The lowest dose of the least toxic drug available should be used to achieve the effect required (Table 43.12). The total dose should be reduced in frail patients and in patients otherwise at risk of toxicity (e.g. patients with epilepsy or heart block). Local anaesthetics should always be injected slowly with repeated aspiration for blood, and with constant verbal contact with, and observation of, the patient. Any change in the patient’s apparent mental state should prompt immediate cessation of injection. Injection of a test dose of a local anaesthetic which contains adrenaline usually results in sudden tachycardia if intravascular injection has occurred.

The addition of adrenaline reduces the speed of absorption from tissues, allowing larger maximum doses, reducing the potential for toxicity and prolonging the action of the local anaesthetic. Adrenaline (1:200 000) typically reduces the maximum serum concentration by approximately 50%. However, the addition of Adrenaline does not reduce local anaesthetic toxicity following intravenous injection.

If toxicity occurs, the injection must be stopped, assistance summoned and the patient assessed. The airway should be checked and oxygen should be administered; this prevents hypoxaemia, which makes fitting more likely and makes arrhythmias more difficult to control. If hypoventilation or apnoea ensue, the lungs should be ventilated using a self-inflating bag or anaesthetic breathing system. Tracheal intubation is required if the patient is unconscious or unable to maintain an airway. Intravenous fluids and vasopressors (e.g. ephedrine 10 mg) may be required to treat hypotension. Arrhythmias may occur and should be treated appropriately (see above). Severe heart block may require an infusion of isoprenaline or pacing. Chest compressions are required if there is no palpable pulse. Convulsions are very common in significant toxicity and administration of an anticonvulsant (e.g. diazepam 10 mg, thiopental 50 mg) is often necessary. The intravenous administration of lipid emulsion has been shown to reduce the effects of systemic toxicity from local anaesthetics, in the presence of cardiovascular collapse and convulsions (note: propofol is not a suitable substitute for lipid emulsion in this scenario).

An initial of bolus of 1.5 mL kg −1 20% lipid emulsion over 1 min is recommended, followed by an infusion at 15 mL kg −1 hr −1.

A maximum of two repeat bolus doses can be given if cardiovascular stability is not restored or deteriorates; 5 min should be left between boluses. The infusion rate can also be doubled to 20 mL kg −1 hr −1 if necessary. The maximum cumulative dose should be limited to 12 mL kg −1 (840 mL for a 70 kg adult).

If lipid has been given, its use should be reported to the international registry at www.lipidregistry.org.

Survival from local anaesthetic toxicity should approach 100%. Good preparation, early recognition and prompt treatment are vital in preventing progression to a situation of poor tissue oxygenation and organ damage.

Injury

Direct physical injury of the patient is a fairly common event in the perioperative period. Most of these injuries are preventable. Tracheal intubation and poor patient positioning are commonly to blame. Nerve, dental and ophthalmic injuries are common causes of litigation against anaesthetists. Thermal and electrical injuries are less common but potentially disastrous. Neurological deficits presenting during the postoperative period have usually been sustained intraoperatively.

Peripheral Nerve Injury

Peripheral nerves may be injured directly, through peripheral nerve blockade or vascular catheter insertion or surgery, indirectly, by poor positioning during anaesthesia, or through ischaemia during severe hypoxaemia or hypotension. Peripheral nerve injury occurs during 0.1% of anaesthetics. The position of the patient during general anaesthesia is the commonest cause of injury. The brachial plexus and superficial nerves of the limbs (ulnar, radial and common peroneal) are the most frequently affected nerves. The usual mechanism of injury to superficial nerves is ischaemia from compression of the vasa vasorum by surgical retractors, leg stirrups or contact with other equipment. Nerve injury may occur as part of a compartment syndrome after ischaemia from poor positioning, particularly when the legs are placed in Lloyd-Davies supports and the patient is positioned head-down. Ischaemic injury is more likely to occur during periods of poor peripheral perfusion associated with hypotension or hypothermia. Nerves may also be injured by traction (e.g. the brachial plexus during excessive shoulder abduction).

Meticulous care is necessary when positioning the patient. Padding should be used beneath tourniquets and to protect pressure points. Extreme joint positions should be avoided. Close surveillance of tourniquet ischaemia times is essential. Although many injuries recover within several months, all patients with a peripheral nerve injury must be referred to a neurologist for assessment and continuing care. Many ulnar nerve palsies occur in patients with an anatomical predisposition, and this may be deduced from a history of numbness after sleep or as a result of posture at work. In these patients, the elbows should not be placed in flexion during surgery.

Injury During Airway Management

Dental damage is the most frequently reported anaesthetic injury and is usually sustained during laryngoscopy. Damage to teeth is much more likely if laryngoscopy is difficult. Most dental injuries result from a rotational force applied to the laryngoscope during attempts to lever the tip of the laryngoscope blade upwards using the upper incisors as a fulcrum. The correct, and much safer, practice is to apply a force upwards and away from the anaesthetist without any leverage on the incisors. Injuries vary from chipped teeth to complete avulsion. The upper incisors are most commonly involved. Preoperative assessment and documentation of dentition are essential. Patients with poor dentition, or in whom a difficult laryngoscopy is anticipated, should be warned of the possibility of dental injury. If a tooth is accidentally avulsed, it should be reimplanted in its socket with minimal interference and a dental surgeon consulted at the earliest opportunity.

Mucosal damage is common during airway management, and mucosal abrasion may be very painful postoperatively. Overinflation of the cuff of a tube in the larynx or trachea may produce local ischaemia, with consequent scarring and stenosis; cuff pressure should be checked regularly, particularly during prolonged surgery and when nitrous oxide is used. Other reported injuries include dislocated arytenoid cartilages (intubation), recurrent laryngeal nerve damage (laryngoscopy), uvular ischaemia (Guedel airway), epistaxis and nasal turbinate fracture (nasal intubation).

Thermal and Electrical Injury

The high-density electrical current of surgical diathermy is a potential source of injury. If the return current path is interrupted by incorrect application of the diathermy pad, then the ECG electrodes or other points of contact between skin and metal may provide an alternative electrical path, producing serious burns. Failure of thermostatic control on warming devices is a potential source of thermal injury. Warming devices should always be used in accordance with the manufacturer’s guidelines. In particular, hot air hoses used to inflate convective warming blankets must never be used alone to blow hot air under the patient’s blankets, as serious thermal injury may result. Ignition of alcohol-based surgical preparation solutions is possible, especially if they are not allowed to evaporate fully and if diathermy is used. Airway fires have occurred during laser surgery to the larynx; it is advisable to use a low inspired oxygen fraction and omit nitrous oxide in this situation.

Fires should be extinguished immediately and the area should be soaked in cool saline or covered with saline-soaked swabs. If the burned area is significant, the opinion of a burns surgeon should be sought.

Vascular Injury and Tourniquets

Arterial catheters may produce significant arterial injury, resulting in ischaemia and, potentially, loss of the distal limb. Arterial tourniquets reduce surgical bleeding but also rob the distal tissue of its perfusion. An absolute maximum duration of 2 h should be observed, and inflation pressures should be just high enough to occlude arterial flow. Typically, a pressure of 200–250 mmHg is adequate for the upper limb, and 250–300 mmHg for the lower limb. Vascular occlusion (e.g. during tourniquet use, aortic cross-clamping) risks distal ischaemia and infarction. Assurance of an adequate arterial pressure and oxygen saturation is important in facilitating distal oxygenation via collateral flow. Parts distal to an arterial occlusion should never be warmed, because this raises local metabolic rate and causes the onset of ischaemia to be more rapid.